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Introduction: Dysphagia, or disordered swallowing, is frequently found in patients with head and 
neck cancer due to side-effects of non-surgical interventions including radiation and 
chemoradiation therapies.  Device-mediated lingual strengthening exercises have a theoretical 
basis for effectively mitigating dysphagia in this population, but these exercises have not been 
shown to be beneficial in the research literature to date.  The primary goal of this study was to 
describe the effects of a device-mediated lingual strengthening protocol, added to standard 
behavioral therapy, on overall swallowing function as reflected by videofluoroscopic analysis.  
The secondary goal was to describe performance related observations regarding participant 
characteristics.  
Methods: This was a secondary examination of the data from six participants in a larger 
prospective experimental study.  Three participants, assigned to the control group, completed 
“standard dysphagia therapy,” and three participants, assigned to the experimental group, 
completed a device-mediated lingual strengthening protocol in addition to “standard dysphagia 
therapy.”  Videofluoroscopic data was collected for all six participants “pre” and “post” treatment.  
Measurements of videofluoroscopic data were taken for seven durational swallowing kinematic 
measures, penetration-aspiration scale scores, and pharyngeal retention scale scores.  These 
measurements were taken to assess airway protection, pharyngeal reside, and overall 
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biomechanical efficiency.  Only penetration-aspiration scale scores and pharyngeal retention 
scores were analyzed, due to feasibility. Analysis consisted of mean differences and a 
normalization to baseline data transformation. 
Results: Findings revealed a lack of consistent improvements in all participants across all 
dependent variables.  However, two observations were made regarding the medical characteristics 
of the participants.  Specifically, the greatest performance was seen by participants who had less 
than one year between finishing chemoradiation therapy and commencing dysphagia treatment 
and who presented with primary lesions in the tonsillar region.  
Discussion: No consistent improvements were found to support the addition of device-mediated 
lingual strengthening exercise to “standard dysphagia therapy,” possibly due to variations in the 
small sample size and flaws in methodology.  However, observations indicate that this form of 
intervention may be useful for patients seeking dysphagia treatment early with primary lesions in 
the tonsillar region.  
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to scale.  Therefore, readers should use caution when examining the figures contained in this text.  
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1.0 INTRODUCTION 
Humans love to eat and drink.  This love makes sense, as both nutrition and hydration are needed 
for survival.  However, humanity’s love of sustenance runs much deeper than basic biology.  
Consuming foods and beverages creates joy and influences appetite, it also provides comfort and 
even a means of personal expression.  We reflect our attitudes toward health, our life experiences, 
and our cultural and spiritual beliefs through our food and beverage choices (Kenny, 2015).  
However, for people with head and neck cancer, this love may be lost, as swallowing impairments 
are common side effects of life-saving cancer treatments.  Prepensely, this study examines the 
potential of a restorative lingual strengthening exercise protocol in mitigating dysphagia in patients 
with head and neck cancer.  
1.1 SWALLOWING 
At first glance, the ability to swallow appears rudimentary, but swallowing is one of the most 
complex physiological processes in the human body.  Successful movement of material from the 
oral cavity to the esophagus requires over 30 oropharyngeal nerves and muscles to work together 
in concert, with both precise timing and movement.  This need for precision is due to pressure 
dynamics.  Proper pressure dynamics can only be obtained when oropharyngeal muscles and 
nerves function at exactly the right times.  To obtain a better understanding of these complexities, 
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clinicians and researchers have developed a system to artificially separate swallowing 
biomechanics into three distinct phases: oral, pharyngeal, and esophageal (Coyle, 2012).  
Biomechanics occurring in these phases are explained below, as swallowing impairments in 
patients with head and neck cancer are often related to biomechanical changes.     
1.1.1 Oral phase 
During the oral phase of thin liquid swallows, material is accepted into the mouth where it is shaped 
into a manageable packet, or bolus (Matsuo & Palmer, 2008).  The bolus is then propelled 
posteriorly into the pharynx by the tongue (Lazarus, J. A. Logemann, C. F. Huang, & A. W. 
Rademaker, 2003).  The oral phase ends when the bolus crosses the ramus of the mandible (jaw) 
and enters the pharynx (Lof & Robbins, 1990).  The more recent literature further divides this 
phase into two sections for the purpose of biomechanical analysis, the oral preparatory phase and 
the oral transit phase (Matsuo & Palmer, 2008).   
The oral preparatory phase is the initial portion of the oral phase, consisting of 
mastication (rotary chewing), salivation, and oral sensation/ enjoyment, as well as bolus formation 
and oral containment (Coyle, 2012).  Bolus formation and oral containment are interrelated as 
material must be successfully held within the mouth for a bolus to be formed.  Successful oral 
holding requires barriers at both the anterior and posterior aspects of the oral cavity to prevent 
passive loss of material (Smith, 2012).  In the anterior position, this is typically accomplished by 
sealing the lips. However, it may be achieved through other compensatory gestures such as a “chin 
up” posture, or even tongue and cheek movements (commonly seen in people who chew with their 
mouth open).  The posterior barrier, a barrier accomplished with linguavelar valving, is formed by 
the tongue base being raised to meet the palatoglossus and styloglossus muscles, forming a tight 
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seal (Matsuo & Palmer, 2008).  For the tongue to function efficiently, it must have a stable base.   
Lingual muscles anchor to both stable attachments (i.e. the skull base), as well as to moveable 
bones such as the mandible and hyoid.  For moveable attachments, stabilization is accomplished 
through opposing muscular contraction forces including the genioglossus, hyoglossus, masseter, 
lateral and medial pterygoids, temporalis, and anterior external laryngeal muscles (Coyle, 2012).  
The oral transit phase is the final portion of the oral phase, in which the bolus is transported 
from the anterior to the posterior boundaries of the oral cavity before successful propulsion into 
the pharynx (Ward, 2009).  Transportation is accomplished through varying pressure dynamics 
created by lingual propulsion, linguavelar valve opening, and velopharyngeal port closure (Matsuo 
& Palmer, 2008).  Intrabolus pressure must be both generated and maintained during this phase.    
The physics principle of Boyle’s Law governs this process.  This law states that within a 
closed system, volume and pressure (potential energy) have an inverse relationship when the 
temperature remains constant (Krauskopf, Beiser, & Carey, 1997).  Lingual movement in a closed 
oral cavity, as seen during oral transit, decreases the volume of the oral cavity which in turn 
increases the pressure (potential energy) within the oral cavity.  As the linguavelar valve opens,  
volume increases creating a pressure gradient which propels the bolus (kinetic energy) out of the 
oral cavity and into the pharynx (Coyle, 2012).  This propulsion is amplified by applied force 
through lingual muscular effort (Nicosia & Robbins, 2001; Smith, 2012).  This combined process 
is referred to as pressure generation.  
Pressure maintenance refers to the valve functioning and timing that must occur to preserve 
intrabolus pressure throughout the swallow (Coyle, 2012).  In the oral transit phase, adequate oral 
containment and velopharyngeal closure keep material out of the pharyngeal and nasal cavities.  
Containment ensures that intrabolus pressure is maintained throughout this phase.   
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Figure 1 depicts some of the events which occur in the oral preparatory and oral transit 
phases of the swallow. Specifically, Panel 1 depicts bolus shaping, and Panel 3 depicts lingual 
propulsion of the bolus into the pharynx. 
Figure 1. Events in the oral preparatory and oral transit phases (liquid bolus) 
1.1.2 Pharyngeal phase 
The pharyngeal phase begins with hyolaryngeal excursion, that is the vertical and anterior 
movement of the hyolaryngeal complex, including the hyoid bone and larynx (laryngeal vestibule, 
aryepiglottic folds, laryngeal ventricle, true vocal folds, and cricoid and thyroid cartilages) (Ward, 
2009).  This movement creates the conditions necessary for a successful swallow, primarily the 
transfer of the bolus into the digestive system and simultaneous airway closure and protection 
(Matsuo & Palmer, 2008).   
For the bolus to enter the digestive system, it must be simultaneously propelled 
successfully through the pharynx and into the esophagus, the airway must close, and the esophagus 
must open.  In the pharyngeal phase, propulsion is accomplished via posterior and inferior 
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movement of the tongue and tongue base along with superior to inferior compression of the tube 
formed by the pharyngeal constrictor muscles (Smith, 2012).   
Airway protection is accomplished through hyolaryngeal excursion which displaces the 
larynx anteriorly and reorients the epiglottis over the laryngeal inlet, and by laryngeal shortening. 
The larynx remains sealed for the duration of this portion of the swallow.  Intrinsic laryngeal 
muscles contract both shortening the laryngeal cavity and sealing the airway through adduction of 
the true vocal folds (Coyle, 2012).  The epiglottis is also thought to play a role in airway protection, 
although evidence suggests that this role has been highly overstated (Jamal, Erman, & Chhetri, 
2015).  Specifically, a combination of intrabolus pressure and hyolaryngeal excursion force the 
epiglottis downward, covering the laryngeal vestibule (Ward, 2009). 
Upper esophageal opening is accomplished through three mechanisms.  First, a neurologic 
inhibitory reflex momentarily reduces the resting pressure of the cricopharyngeal portion of the 
inferior pharyngeal constrictor muscle, which serves as the inlet to the upper esophageal sphincter 
(Coyle, 2012).  Second, movement during hyolaryngeal excursion displaces the cricoid cartilage 
both vertically and anteriorly (Smith, 2012).  As the cricoid cartilage attaches to the anterior 
portion of the upper esophageal sphincter, the vertical and anterior movement of the hyolaryngeal 
complex pulls the upper esophageal sphincter open.  In healthy individuals, this movement 
coincides with total relaxation of the upper esophageal sphincter (Coyle, 2012).  Third, ongoing 
pressure generation, by the tongue base and pharyngeal constrictors, continues to propel the bolus 
into the esophagus (Matsuo & Palmer, 2008). 
Figure 2 depicts biomechanical events occurring in the pharyngeal phase.  Specifically, 
Panel 1 depicts the pharynx and larynx at rest. Panel 2 depicts hyolaryngeal excursion, epiglottic 
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inversion, and pharyngeal constriction. The last panel, Panel 3, depicts material passing into the 
upper esophageal sphincter and the start of the esophageal phase.   
Figure 2. Events in the pharyngeal phase 
1.1.3 Esophageal phase 
The esophageal phase is the final stage of the swallow.  During this phase, the bolus is propelled 
downward through the upper esophageal sphincter and into the esophagus, a 25-centimeter 
fibromuscular tube which passes behind the trachea and heart, and through the diaphragm (Marieb, 
2011).  Propulsion is accomplished through peristaltic, or wave-like muscle contractions, which 
force swallowed material through the esophagus and into the stomach (Matsuo & Palmer, 2008).  
1.1.4 Biomechanics summary 
While the oral, pharyngeal, and esophageal phases offer a well-ordered explanation of swallowing, 
they are not entirely accurate.  In reality, phases do not occur in isolation, and biomechanics in one 
phase affect the next phase (Matsuo & Palmer, 2008).  Phases also overlap (Coyle, 2012), requiring 
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the body to multi-task.   As swallowing biomechanics are precise, even minor changes may disrupt 
a person’s ability to swallow.  This disruption is called dysphagia.   
1.2 DYSPHAGIA 
Dysphagia, i.e. disordered swallowing, is not a disease but a consequence of other processes, such 
as vascular trauma, neurogenic disease, and neoplasm (cancer) (Matsuo & Palmer, 2008). 
Iatrogenic dysphagia is a special category of dysphagia, involving an acquired pattern of 
disordered swallowing caused by medical interventions such as anesthesia, prolonged 
endotracheal intubation, operative trauma, radiation therapies, and pharmaceutical side-effects.  
This type of dysphagia will be discussed in further detail later in the paper, as it is the primary 
focus of this study, due to the prevalence of iatrogenic dysphagia in patients with head and neck 
cancer. 
Regardless of the etiology, dysphagia impacts many areas of a patient’s life, including both 
their personal and psychosocial health.  Negative personal health outcomes may stem directly from 
dysphagia, including life-threatening conditions such as airway obstruction, inadequate nutrition, 
inadequate hydration, and difficulties ingesting medications and controlling blood glucose levels  
(Coyle, 2012; Matsuo & Palmer, 2008).  Dysphagia may also result in negative health outcomes 
due to associated complications, such as aspiration.  Aspiration is the penetration of material into 
the larynx and trachea below the level of the vocal folds (Coyle, 2012), this penetration may lead 
to the development of bronchopulmonary diseases.   The most common bronchopulmonary disease 
associated with aspiration is pneumonia (Marik 2001).  Dysphagia, while not an independent 
8 
predictor of pneumonia, does place individuals at an increased risk for the development of this 
serious, and potentially fatal, condition (Langmore et al., 1998). 
1.3 CURRENT PRACTICES IN DYSPHAGIA MANAGEMENT 
As dysphagia may lead to severely negative personal health outcomes, health professionals who 
specialize in dysphagia aim to mitigate patient harm and facilitate improvement where possible. 
Speech-language pathologists, or clinicians, are relevant service providers for patients with 
dysphagia, due to their roles in diagnosis and management.  Clinician involvement may take many 
forms, including administering screening and assessment measures, as well as planning, 
implementing, and tracking patient progress during treatment.     
1.3.1 Dysphagia screening 
Screening protocols are an essential part of comprehensive health care, as screening measures 
identify patients who may be at risk for specific diseases or disorders.  For a screening tool to be 
effective, it must be quick, accurate, and easy to administer.  Consequently, screening protocols 
are simple by design, typically producing an easy-to-read “pass or fail” outcome.  While specialists 
may administer screening tests, many tests may also be administered by non-specialists.  In regards 
to screening measures specific to dysphagia, numerous options are currently available.  These 
options range from formal protocols, such as the Yale Swallow Protocol (Suiter, Sloggy, & Leder, 
2014) and the Toronto Bedside Swallowing Screening Test (TOR-BSST) (Martino et al., 2009),  
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to informal approaches such as patient observation.  This diversity allows health care professionals 
to choose screening measures based on the needs of their patient.      
1.3.2 Dysphagia assessment 
In contrast, dysphagia assessment is more complex.  These measures must be administered by 
specialists and provide substantially more information.  Consequently, dysphagia assessments may 
result in a formal dysphagia diagnosis, whereas screening cannot.  Dysphagia assessment also 
takes many different forms, and each different form provides unique information about different 
aspects of a patient’s life.  Therefore, a comprehensive assessment battery must feature different 
forms of assessment.  Commonly used forms of dysphagia assessment include patient reports, non-
instrumental evaluations, and instrumental evaluations.  
Patient reports are uniquely valuable to clinicians as they provide information from the 
patient’s perspective.  Specifically, these approaches enable clinicians to ascertain knowledge 
regarding the patient’s personal history, medical history, their current knowledge of their disorder, 
their goals, means of support, and their personal view of the impact of their disorder.  This 
information is vital to forming an accurate diagnosis as well as to guiding management 
recommendations and creating an appropriate intervention plan.   Patient reports also take many 
different forms, ranging from informal patient interviews to standardized questionnaires, such as 
the Eating Assessment Tool (EAT-10) (Cheney, Siddiqui, Litts, Kuhn, & Belafsky, 2015).   
Non-instrumental evaluations and observations also play key roles in assessment.  These 
evaluation measures are typically performed by the clinician and commonly consist of non-
standardized procedures such as oral motor exams, speech tasks, and clinical bedside swallow 
evaluations.  Non-instrumental assessments provide the clinician with information relating to the 
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nature and cause of dysphagia, as well as information regarding the patient’s current abilities. 
Clinicians then use this information to form hypotheses regarding the patient’s physiology.  This 
information is important as management recommendations are often based on correcting the 
underlying physiological difficulty.  For some patients, this provides sufficient information, and 
treatment recommendations can be made at this stage.  However, other patients may require 
additional forms of assessment. 
Instrumental evaluations are used when the information acquired through other forms of 
assessment is insufficient, and a more detailed view of specific aspects of swallow physiology is 
necessary to provide effective dysphagia management.  For this study, only videofluoroscopic 
swallow studies (VFSS) will be examined in detail, as this was the only form of instrumental 
evaluation used.   
Videofluoroscopic swallow studies (VFSS) are x-ray imaging procedures which enable 
clinicians to observe internal oral, pharyngeal, and laryngeal structures while the patient is 
swallowing.  This form of instrumental assessment is currently one of the most commonly used 
assessments in clinical practice (Krisciunas, Sokoloff, Stepas, & Langmore, 2012).  However, 
there are mild risks associated with the procedure.  X-ray beams are a form of high-energy 
radiation and radiation may damage both bodily tissues, and DNA.  As these effects are 
cumulative, clinicians must always limit their patients’ exposure and rely on clinical judgment 
when recommending these tests (Smith, 2012).  Additionally, patients are not always appropriate 
for this form of testing, as successful completion requires patients to follow instructions accurately 
as well as sit or stand upright independently.  Given that many patients with dysphagia are either 
hospitalized or have complex medical comorbidities, this form of assessment is not always feasible 
or appropriate (Ward, 2009). 
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For patients who can undergo this form of assessment, the information obtained is 
extremely valuable.  Videofluoroscopic films permit observations of internal structures during the 
swallow, meaning that clinicians can use videofluoroscopic films to observe biomechanics, ideally 
identifying or ruling out physiological causes of dysphagia.  These studies also provide clinicians 
with opportunities to test the efficacy of different compensatory treatment strategies. Also, the 
videos created by videofluoroscopic swallow studies may be analyzed to obtain quantitative values 
that clinicians and researchers may use to guide both patient management and contribute to clinical 
science.  Many different protocols have been established for this type of analysis; some are favored 
by clinicians and others by researchers.  This paper will focus on three specific measures used to 
analyze videofluoroscopic video, as these measures were used in this study.   
First, Rosenbek, Robbins, Roecker, Coyle, and Wood (1996) developed a penetration-
aspiration scale which is useful to both researchers and clinicians as the scale quantifies the 
severity of airway infiltration during the swallow, along eight ordinal points.  Specifically, the 
scale identifies the depth to which material penetrates the larynx/ airway, any presence of laryngeal 
or tracheal residue post swallow, and whether an overt reflexive response occurs to clear material 
through the assignment of numerical values.  In this way, the scale provides an estimate of the risk 
that respiratory tissue exposure to swallowed material that has entered the airway may cause 
adverse respiratory system outcomes.  However, the scale does not quantify the timing or amount 
of material aspirated/ penetrated (Rosenbek et al., 1996).  Therefore, clinicians must use other 
analysis measures to add this information to their analysis. 
One type of measure which may be used is a pharyngeal retention scale, such as the one 
developed by Eisenhuber et al. (2002) after adapting work from Perlman et al. (1989).  Their scale 
consists of a three-points scale and is used to measure post–swallow residue in the valleculae and 
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pyriform sinuses.  Scale values range from one to three, and numbers correspond to the estimated 
height of the area of residue within a given cavity, using the height of the anatomical cavity 
(valleculae, pyriform sinuses) as the reference.  In this way, the pharyngeal retention scale allows 
clinicians and researchers to quantify the pharyngeal residue a patient may exhibit in a standardized 
way.  As a result, this scale may be used to document patient progress as well as to research the 
different factors impacting residue retention.  However, one drawback of this scale is that the 
lowest score comprises “0-25% height of the residue column” and does not distinguish between a 
thin coating of barium with an anatomical cavity and residue filling up to 25% of the cavity.  This 
drawback could potentially limit the scale’s sensitivity, i.e. the scale’s ability to detect meaningful 
change, particularly in patients with less severe pharyngeal retention.  Lof and Robbins (1990) 
used a three-point scale that accounted for “no visible residue” and “coating” of residue, a one-
dimensional line of residue seen on the mucosal surface after the swallow.  To remedy this 
drawback, we combined these scales to include the addition of a zero value to the scale to 
differentiate between no visible residue and a one-dimensional, thin layer of residue coating, 
resulting in a five-point scale (see Table 6, 2.7 Measurement, pg. 42).   This modified version of 
the pharyngeal retention scale was used in this study.   
However, not all videofluoroscopic analysis measures consist of scale scores.  For example, 
kinematic durational measures may also be taken.  The original protocol for conducting kinematic 
durational measures was created by Logemann, Kahrilas, Begelman, Dodds, and Pauloski (1989), 
whose work has provided foundational knowledge regarding swallowing function and patient 
responses to treatment in a diverse range of patient populations. The protocol consists of 
identifying specific kinematic swallowing events and analyzing the relationships among them. 
Their protocol was further refined by Lof and Robbins (1990), who also compared frame numbers 
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on the VFSS videos, and then calculated the timing of swallowing events based on frame numbers.  
Both methodologies are still widely in use today.  Kinematic analysis has been used to establish 
norms for patient populations regarding specific swallowing patterns, including oral transit 
durations, pharyngeal transit durations, upper esophageal sphincter opening durations among 
others.  Today, kinematic analysis is primarily used by researchers to quantify patterns of 
improvement or regression by comparing values found in patients with dysphagia to norms 
established in healthy patient populations. 
In summary, dysphagia assessment is multi-dimensional, necessitating the use of many 
different forms of evaluation.  This necessity is due to the strengths and weaknesses of different 
evaluation forms, as each provides different information to the clinician.  Therefore, health care 
providers must use their clinical judgment to ensure they are providing the best assessments 
available for their individual patients. 
1.3.3 Dysphagia treatment 
Dysphagia treatment must also be individualized to the patient.  One way clinicians approach this 
is by customizing intervention using two different types of techniques, compensatory and 
restorative.  Compensatory techniques rely on principles of biomechanics and the physics of fluid 
flow to optimize bolus transfer and airway protection.  Commonly used techniques include posture 
alterations, such as lateral head flexion (head tilting) or rotation (head turning), and modifications 
to bolus volume (small bites and sips) and viscosity (thickening) (Cabib et al., 2016).  In contrast, 
rehabilitative or restorative techniques are designed to produce an enduring change in swallowing 
physiology over time (Cabib et al., 2016), and are best for patients who may improve.  Commonly 
used techniques include stimulation techniques and exercise.  Stimulation techniques, in particular, 
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thermotactile and electrical stimulation techniques, have recently regained increased clinical 
interest although more evidence of efficacy is currently needed (Christiaanse et al., 2011).  
Contrastingly, exercise rehabilitative techniques currently have the greatest empirical support 
within the dysphagia literature, particularly regarding strengthening exercises (Carnaby-Mann, 
Crary, Schmalfuss, & Amdur, 2012; Fujiu & Logemann, 1996; Robbins et al., 2005; Rogus-Pulia 
et al., 2016; Wada et al., 2012).  These exercises will be the focus of this study. 
1.3.4 Exercise overview 
As exercise rehabilitative techniques have strong support in the dysphagia literature (Carnaby-
Mann et al., 2012; Fujiu & Logemann, 1996; Robbins et al., 2005; Rogus-Pulia et al., 2016; Wada 
et al., 2012), clinicians should obtain a basic understanding of exercise science.  Cooper et al. 
(1999), defines exercises as “planned, structured, and repetitive bodily movement done to improve 
or maintain one or more components of physical fitness” (p. 143).  Garber et al. (2011) clarify this 
by defining the five most important aspects of physical fitness as cardiovascular endurance, body 
composition, flexibility, muscular strength, and muscular endurance.  This paper will focus on 
muscular strength training, as this form of exercise was the primary focus of this study.   
The most common form of muscular strength training involves exercises with the addition 
of external resistance, called resistance training (Garber et al., 2011).  In resistance training, 
muscular exercise occurs via muscular contractions which may be divided into two categories, 
static and dynamic.  Static, or isometric contractions, occur when a muscle generates force without 
changing length (Garber et al., 2011). Dynamic muscle contractions occur when a muscle 
generates force while either lengthening (eccentric) or shortening (concentric) (Garber et al., 
2011).  
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Other important aspects of resistance training include variations in intensity, load, volume, 
repetition, and timing (American College of Sports Medicine, 1998).  When targeting strength, the 
American College of Sports Medicine recommends that strength training should be completed on 
at least two non-consecutive days each week, with a volume of one to three sets of eight to 12 
repetitions for healthy adults (American College of Sports Medicine, 1998).  Also, a rest period of 
two to three minutes should occur between sets for higher intensity exercises that use heavier loads, 
and one to two minutes rest should occur between lower intensity exercises with light loads.  The 
load, or intensity, of the workout, should consist of 60-70% muscle group current maximum 
strength for novice to intermediate exercisers, to 80-100% for advanced practitioners (American 
College of Sports Medicine, 1998).     
1.3.5 Muscular strength training in dysphagia therapy 
Muscular strength training in dysphagia therapy has taken many different forms. For example, 
Shaker et al. (2002) developed a “head lift” exercise which has been shown to produce small 
increases in upper esophageal sphincter opening diameter and duration, although replication of 
these findings was inhibited due to high patient discomfort during the exercise.  In contrast, Wada 
et al. (2014) developed a more specific mandible depression exercise that also shows promise in 
increasing upper esophageal sphincter opening and hyolaryngeal excursion, without high attrition 
rates.  These exercises are both currently used in clinical practice (Krisciunas et al., 2012).  
Notably, the most established form of muscular strength training exercise in the dysphagia research 
literature was identified by Robbins et al. (1995).  Here, the researchers originally identified the 
tongue to be of particular interest in pressure generation.  Their focus, for nearly 20 years, on 
lingual exercise has resulted in studies demonstrating the efficacy of isometric lingual strength 
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training in patients following stroke (Robbins et al., 2007) and the healthy aging population 
(Robbins et al., 2005). 
While lingual strengthening exercise protocols have established support within the 
dysphagia literature, exact administration of these protocols is still under debate.  Specifically, 
some clinicians prefer to administer lingual strengthening exercise protocols using non-
standardized objects for resistance, such as a tongue depressor.  However, other clinicians prefer 
implementing strength training exercises uses specially designed and calibrated devices, referred 
to as device-mediated lingual strengthening protocols.  Device-mediation has unique advantages 
in that it allows for exact measurement of exercise targets and load.  In this way, using a device 
helps clinicians ensure that they are adhering to the American College of Sports Medicine 
guidelines.  Device-mediation is also beneficial for the patient, as it allows for biofeedback, 
wherein the consumer may directly observe their target load accuracy and individually monitor 
their overall progress.   
Today the most well-researched tool for the application of device-mediation in dysphagia 
treatment is the Iowa Oral Performance Instrument (IOPI) device.  This device is a portable 
handheld tool that measures pressure using a pneumatic sensor.  An air-filled balloon is placed in 
the mouth and compressed between the tongue and the hard palate.  The sensor relays pressure 
information through a digital converter where it is reported in kilopascals (kPa).  The original 
prototype was invented by Dr. Erich Luschei in 1988 (IOPI Medical, 2013).  Originally, this device 
was intended to measure articulation-related tongue strength and endurance.  However, it has since 
expanded to include research and practical application in both lingual strength and hand strength 
(Adams, Mathisen, Baines, Lazarus, & Callister, 2013).  
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1.3.6 Efficacy studies 
Support for the use of lingual strengthening exercise is strong within the dysphagia research 
literature, particularly concerning patients with conditions such as normal aging, and stroke 
(Adams et al., 2013).  In healthy older adults, participants treated with an Iowa Oral Performance 
Instrument (IOPI) device achieved significant increases in tongue strength as well as overall 
tongue bulk (Robbins et al., 2005).  Older adults treated with an Iowa Oral Performance Instrument 
(IOPI) device also showed less restrictive diets, less perceived effort during swallows, an 
improvement in overall quality of life, and decreases in both hospitalizations and pneumonia 
diagnoses when compared to controls who did not receive device-mediated treatment (Rogus-Pulia 
et al., 2016).  Regarding patients post stroke, research has shown that patients treated with an Iowa 
Oral Performance Instrument (IOPI) device gained an increase in isometric lingual strength, 
swallowing pressure when compared to baseline (Robbins et al., 2007).   
Notably, all of the studies above used device-mediation when administering lingual 
strengthening exercise.  To date, very little research exists regarding the efficacy of more informal 
tools used for resistance such as tongue depressors.  The only study examining this issue, known 
to the principal investigator (NB), was published by Lazarus and colleagues (2003).  This study 
examined the efficacy of two different methods of administration of lingual strengthening 
exercise and compared both to a “no exercise” control group. Results demonstrated that 
lingual strengthening exercise, regardless of method of administration, causes a significant 
increase (p=.04) in maximum tongue strength, as measured by an Iowa Oral Performance 
Instrument (IOPI) device.  Results also revealed that there was no difference between the two 
groups in tongue strength post-baseline.  These results indicate that both device-mediate 
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exercise and informal resistance applicators have the same efficiency. However, as this study 
has not been replicated, further research needs to be conducted regarding this issue.   
Another paucity in the research literature regarding lingual strengthening exercise concerns 
diverse patient populations.  While patients with dysphagia due to healthy aging and stroke have 
demonstrated benefits following lingual strengthening exercise treatment protocols, other patient 
populations have not been explored.  This scarcity needs to be resolved as different patient 
populations present with different difficulties, needs, and concerns.  Distinctiveness is particularly 
relevant concerning patients with head and neck cancer, as the nature of their underlying condition, 
cancer, and the treatment options for this condition create unique concerns.   
1.4 HEAD AND NECK CANCER 
Patients with dysphagia resulting from cancerous lesions in the head and neck are a unique patient 
population.  Specifically, patients with head and neck cancer are highly variable and rarely respond 
to treatments in the same way (Krisciunas et al., 2012).  While the current research literature is 
robust regarding some sources of patient variation, little is known about other aspects.  These 
lacking areas of the research literature need to be explored with haste, particularly because of the 
prevalence of this disease.  Head and Neck Cancer is the sixth most commonly diagnosed cancer 
worldwide with 635,000 people newly diagnosed each year (Nund et al., 2014).  Additionally, 
statistical projections predict a rise in diagnosis in the near future due to the increasing incidence 
of human papillomavirus (HPV), which is a virus that may lead to the development of head and 
neck cancer (Callaway, 2011). 
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Given the increasing incidence and the burden of this disease, health care providers need 
to be able to provide effective treatments, and detailed information regarding how individuals react 
to different treatments is crucial to accomplishing this goal (Krisciunas et al., 2012).   This study 
attempts to fill in these gaps by examining participant characteristics including personal 
demographic information and cancer-related medical history.  Therefore, this paper will focus on 
existing literature and trends regarding these concepts below.   
1.4.1 Personal demographic information 
Personal demographic information is collected by all medical facilities, as it provides a basic 
patient profile and allows for identification.  This study will focus on two specific items of patient 
demographic information, age, and gender, as these items were examined in relation to variations 
in participant improvement in this study.   
In regards to gender, research has demonstrated that men are two to three times more likely 
to develop head and neck cancer during their lifetimes than women (National Cancer Institute, 
2017).  As more men are diagnosed with head and neck cancer, more research regarding this 
condition has been conducted on males.  Therefore, less is known about how women respond to 
treatment.  This information is imperative to providing effective services moving forward, as men 
and women may present with unique symptoms and react differently to treatments (Mikaeli, 
Farrokhi, Bishehsari, Mahdavinia, & Malekzadeh, 2006).  Additionally, the rate of head and neck 
cancer in women has been rising for several decades (National Cancer Institute, 2017). Therefore, 
more research needs to be done regarding how gender impacts treatment success in patients with 
head and neck cancer.    
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Similarly, age is another patient demographic factor which requires further investigation.  
Specifically, the current research literature has demonstrated that people over the age of 40 have a 
higher risk of developing head and neck cancer (National Cancer Institute, 2017).  While this 
information is useful to prescribing physicians, it does little to inform clinicians about how to 
approach treatment based on age.  For example, patients diagnosed in their 40s have a significantly 
higher survival rate than those diagnosed in the 70s (National Cancer Institute, 2017).  However, 
the literature has found that some older adults with head and neck cancer still experience long-
term benefits from aggressive CRXT (Maggiore et al., 2013).  Research literature has also 
demonstrated that elderly patients with head and neck cancer may have unique concerns, setting 
them apart from younger patients, especially involving polypharmacy, i.e. improper medication 
management (Maggiore et al., 2014), and toxicity (Maggiore et al., 2013).  While sufficient 
research does not yet exist to identify those who can tolerate more intense treatments reliably, 
team-based approaches seem to lead to better outcomes and identification in this patient population 
(Maggiore, 2016).   
In summary, while the research literature has strong documentation concerning the 
prevalence of head and neck cancer in specific patient demographic categories, very little 
information is currently available regarding how these characteristics impact treatment.   
Therefore, more research needs to be done regarding the effects of patient characteristics for 
clinicians to provide truly individualized services. 
1.4.2 Medical history factors 
A patient’s medical history may also provide clues to clinicians regarding how a patient may 
respond to different forms of treatment.  For the purpose of this study, three specific factors will 
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be described in detail, as these factors were the only aspects explored in this study.  Specifically, 
this paper will delve into how tumor presentations, cancer treatments, and timing may impact 
patient treatment outcomes.    
The first source of varied responses to treatment in patients with head and neck cancer 
stems from the features of cancerous tumors.  Tumor presentations are heterogeneous, showing 
variability in size and rate of advancement.  Accordingly, Pierre Denoix developed a standardized 
classification system for tumor severity in the 1940s, called TNM staging (Brierley, 2006).  This 
system has since been adopted globally by physicians and health organizations such as the World 
Health Organization (Brierley, 2006).  Today, this system is used to classify head and neck cancers 
worldwide.  In this system, “T” refers to the size of the primary tumor, “N” refers to lymph node 
involvement, and “M” refers to distant metastases.   Table one provides definitions of the TNM 
staging definitions used for patients with head and neck cancer.   
Table 1: TNM staging used for patients with head and neck cancer 
Staging Definition 
T TX Primary tumor cannot be assessed 
T0 No evidence of tumor 
Ti Abnormal cells that have not spread 
T1 Tumor two centimeters or less 
T2 Tumor between two and four centimeters 
T3 Tumor greater than four centimeters 
T4 Advanced local disease 
N NX Lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis, one ipsilateral lymph node, less than three centimeters 
N2 Metastasis, one ipsilateral lymph node, multiple ipsilateral lymph nodes, or 
bilateral or contralateral lymph nodes, between three and   six centimeters 
N3 Metastasis in lymph node, greater than six centimeters 
M M0 No distant metastasis 
M1 Distant metastasis 
(National Cancer Institute, 2016a) 
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Tumor staging matters for patients, as staging has been linked to survival rates (Lee et al., 
2016) and may determine a patient’s eligibility for treatment (Boscolo-Rizzo, Maronato, 
Marchiori, Gava, & Da Mosto, 2008).  Treatment eligibility is also important, as different 
treatments have been linked with various overall outcomes, particularly concerning quality of life, 
due to the differences in side effects associated with different treatments (Boscolo-Rizzo et al., 
2008).  These differences constitute the second main factor for patient variation.  Specifically, that 
patient outcomes vary based on the type of primary cancer treatment they received.   
Currently, there are two main categories of primary cancer treatments available for patients 
with head and neck cancer, surgical and nonsurgical.  Surgical treatment options range from 
minimally invasive, using endoscopic instrumentation (Goh, Ng, & Teo, 2010), to more invasive 
interventions such as surgical removal of the larynx (laryngectomy) or tongue (glossectomy) 
(Boscolo-Rizzo et al., 2008).  Nonsurgical treatment options also vary, including radiation and 
chemoradiation therapies.  These treatments destroy and inhibit cancer cells through alternative 
methods including x-ray technology and pharmaceuticals.  These treatments will be the focus of 
this study.     
Radiation therapy, also called external beam radiation therapy (XRT), is a nonsurgical 
cancer treatment which aims to eliminate and prevent cancerous tumors by destroying cells or 
inhibiting growth and division.    Radiation therapy is implemented as both a standalone therapy 
and as a therapy supplement to surgical resection (National Cancer Institute, 2016b).   Radiation 
therapy may be used on both large and small areas of the body and is usually given daily for several 
weeks in an outpatient clinic or treatment center (Palm & Johansson, 2007).  During treatment, an 
x-ray machine directs one or more beams of high-energy x-rays (typically photon beams) at a
patient's tumor (Palm & Johansson, 2007).  Whether or not a patient received radiation therapy is 
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crucial information for clinicians to know, as these patients present with very specific side effects 
related to radiation, many of which may be caused by iatrogenic dysphagia (Lazarus et al., 1996). 
Chemotherapy is a different form of nonsurgical primary cancer treatment.  Instead of 
relying on x-ray beams, chemotherapy uses drugs to destroy, stop, or slow the growth of cancer 
cells (National Cancer Institute, 2016b).  Chemotherapy may be used before surgery or radiation 
therapy to increase the success rate of planned surgical or radiation treatments (Forastiere et al., 
2003), or it may be used following radiation or surgical resections to treat the risk of residual 
disease based on disease staging (National Cancer Institute, 2016b).  Chemoradiation therapy 
(CXRT) refers to the combination of chemotherapy and radiation therapy.  This combination is 
used to increase the curative effect.  The theoretical basis for this use is based on the “Steel 
Paradigm,” which was introduced by Steel and Peckham (1979).  In this article, the authors posited 
that the two treatments enhance cancer survival rates because they are directed towards different 
parts of the body and work independently. Specifically, radiation acts to target localized tumors 
whereas chemotherapy drugs eliminate distant lesions.  While the actual biological underpinnings 
of the combination effect of are more substantially more complex, consisting of specific 
interactions, this theoretical model provides a basic understanding of the enhanced therapeutic 
effects which may be obtained through chemoradiation treatments.   
Clinicians need to know which primary cancer treatment patients received because they 
present with different side effects, one of which may be dysphagia.  Effective dysphagia 
management requires this information.  Additionally, treating clinicians need information 
regarding when these treatments were administered, as the associated side effects change over time 
(Logemann et al., 2008).  Therefore, the third main factor which influences patient variation in 
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presentation and responsiveness to treatment, related to patient cancer-related medical history is 
how much time has elapsed since nonsurgical cancer treatment.   
First, patients who had little time pass between completing nonsurgical cancer treatments, 
and commencing dysphagia treatment may still be experiencing the short-term side-effects of 
primary cancer treatments.  For those who received radiation therapy, this likely includes both 
tissue and sensory changes, as radiation destroys diseased tissue and its microvascular supply, 
causing changes in adjacent tissue architecture and integrity.  Short-term, acute tissue changes 
range from relatively mild effects such as erythema, or reddening of tissue, to extreme adverse 
outcomes such as osteoradionecrosis, i.e. bone death (Rogers, D'Souza, Lowe, & Kanatas, 2015).  
Common acute tissue conditions relating to dysphagia include xerostomia (dry mouth), mucositis 
(inflammation/ ulceration of mucous membranes specifically of the mouth), and desquamation 
(skin peeling) (Lazarus et al., 2000).  Sensory changes may also occur in the short term.  Patient 
reports indicate that dental sensations and oral/pharyngeal tactile sensations are often altered.  
Taste sensations may also change or become damaged (McLaughlin, 2013).  Unsurprisingly, 
patients regularly report discomfort during meals (McLaughlin, 2013). 
While these side effects are specific to radiation therapy, they may also be experienced by 
patients who underwent chemoradiation therapy, as this is the combination of chemotherapy and 
radiation treatments.  Therefore, these patients may develop all of the previously discussed short-
term sequelae associated with radiation therapy in addition to those associated with chemotherapy, 
such as fatigue, loss of appetite, fungal infections, nausea, vomiting, and pain (Kim et al., 2001).  
It should also be noted that the combination of chemotherapy and radiation therapy heightens the 
intensity of adverse sequelae associated with both radiation and chemotherapy therapy (Kim et al., 
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2001).  Therefore, patients who underwent chemoradiation may present differently than those who 
underwent radiation therapy, even though the side effects of both treatments are similar.   
Long-term side effects of radiation and chemoradiation treatments may also vary from the 
previously discussed short-term side effects.  Tissue toxicity and permanent microvascular damage 
are long-term effects of radiation, both in turn, lead to adverse sensory, motor, and tissue integrity 
outcomes.  For example, soft tissue and muscle fibrosis, i.e. hardening due to devascularization 
(destruction or obstruction of blood vessels), is a long-term effect of radiation therapy.  Fibrosis 
then affects both tissue compliance and sensation, even compressing nerve fibers, leading to 
demyelination and neuropathy (Delanian, Lefaix, & Pradat, 2012). Other serious long-term effects 
of these treatments include trismus, or muscle spasms of the jaw (Kraaijenga et al., 2015), vascular 
changes such as damage to arteries, arterioles, and capillaries (Yusuf, Sami, & Daher, 2011), and 
radiation-induced bulbar palsy (Shapiro, Rordorf, Schwamm, & Preston, 1996).  Additionally, 
people who underwent chemoradiation therapy may also experience these long-term side effects.  
However, these patients may experience additional effects as well such as hormone irregularities, 
due to thyroid damage, difficulties with memory, and peripheral neuropathy (nerve damage), as 
these conditions have been shown to be long-term side effects of chemotherapy (Kim et al., 2001).  
As substantial variation exists between the long-term and short-term side effects of 
nonsurgical primary cancer treatments, there is also substantial variation in how patients who 
underwent these treatments present.  Therefore, clinicians need to keep these differences in mind 
when planning intervention, particularly when planning for dysphagia management.  However, 
knowing the side effects of nonsurgical primary cancer treatment is not enough.  Clinicians treating 
dysphagia also need to know specific information regarding how these side effects influence each 
patient’s swallowing function.    
26 
1.4.3 Dysphagia in patients with head and neck cancer  
As previously discussed, patients with radiation/ chemoradiation-induced dysphagia are a 
heterogeneous patient population.  While the observed clinical signs of dysphagia are diverse and 
vary based on many factors (Krisciunas et al., 2012), some clinical signs have been consistently 
demonstrated by patients.  These signs include increases in pharyngeal retention/ residue as well 
as increases in penetration and aspiration events (Lazarus et al., 2000; Logemann et al., 2008).  
These patterns of swallowing dysfunction following nonsurgical cancer treatment are directly 
linked to difficulties with pressure generation and maintenance and may be broken down by 
swallowing phase. 
In the oral phase, decreases in pressure generation and maintenance are due to impairments 
in tongue range of motion and strength.  These deficits then lead to poor oral transit and posterior 
oral valving (Lazarus et al., 2000).  The resulting reduction in the generation and maintenance of 
intrabolus pressure then creates trickle-down effects such as pharyngeal retention/ residue and 
reduced airway protection due to the interdependent nature of swallow biomechanics.    
In the pharyngeal phase, patients with radiation/ chemoradiation-induced dysphagia often 
present with impaired hyolaryngeal excursion (both superior and anterior), delays in the initiation 
of the pharyngeal motor response, reduced laryngeal closure, reduced epiglottic inversion, and 
reduced pharyngeal constriction.  These changes further reduce the already diminished intrabolus 
pressure generation and maintenance, further compounding the effects noted in the oral phase 
(Logemann et al., 2008).   
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The esophageal phase of the swallow in this patient population is marked by reduced upper 
esophageal sphincter opening diameter and duration (Logemann et al., 2008).  Decreases are due 
to both tissue changes, such as reductions in pliability, and the previously mentioned decreases in 
intrabolus pressure.   
While these patterns have been observed in many patients with radiation/ chemoradiation 
-induced dysphagia, it is important to keep in mind patient variability.  Therefore, clinicians should
always be aware that while these patterns are common, they may not be present in all patients.  As 
a result, dysphagia management must be individualized to be effective. 
1.4.4 Current treatments for radiation/ chemoradiation-induced dysphagia 
Unfortunately, there is little consensus in the field today regarding how best to individualize 
treatment (Krisciunas et al., 2012).  In fact, there is little consensus in the field regarding best 
practices for even approaching dysphagia treatment in this population (Krisciunas et al., 2012).  
Perhaps this lack of consensus explains why much of the recent emerging literature emphasizes 
treatment batteries, containing multiple exercises, instead of individualized intervention plans.   
For example, in Virani (2015), researchers examined the effectiveness of a dysphagia 
treatment battery consisting of three different exercises specifically aimed to strengthen muscles 
involved in tongue retraction, hyolaryngeal excursion, and pharyngeal constriction.  These 
exercises included sustained head-lifts (Shaker et al., 2002), dry swallows with a tethered tongue 
(Fujiu & Logemann, 1996), and pharyngeal squeeze (Fuller, Leonard, Aminpour, & Belafsky, 
2009).  Patients who received the exercise-based therapy saw an increase in oral intake and a 
decrease in feeding tube dependence when compared to those who did not receive exercise-based 
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therapy.  This study suggests that exercise therapy protocols can have a positive effect on outcomes 
for patients with radiation/ chemoradiation-induced dysphagia.   
A similar study was conducted by Hutcheson et al. (2013) and reported similar findings. 
However, this study used a different exercise protocol.  Specifically, the experimental exercise 
protocol consisted of many varied tasks including head-lifts, lingual protrusion/ retraction, jaw 
stretches, effortful swallows, falsetto, yawn, gargle, and intentional vocal fold closure before 
swallowing with or without bearing down.  Patients who received this exercise treatment 
experienced more positive results when compared to those who did not receive exercise treatment, 
as defined by greater oral intake and less feeding tube dependence.    
Another similar study was conducted by Carnaby-Mann et al. (2012), who developed a 
different exercise program called “Pharyngocise.”  This protocol consisted of tongue press, 
falsetto, hard swallow, and jaw resistance/strengthening exercises.  This study examined the 
effectiveness of this treatment by comparing the performance of patients who completed this 
exercise program to patients who received “usual care” and patients who received a “sham 
swallowing intervention.”  The researchers found that patients who completed the “Pharyngocise” 
protocol experienced less musculature deterioration than those who completed the “usual care” 
protocol or “sham swallowing intervention.”  Additionally, those who completed the 
“Pharyngocise” protocol experienced better overall functional swallowing abilities including, 
mouth opening, chemosensory acuity, and salivation rate, than participants who completed other 
protocols.   
Interestingly, this study was the only one to include lingual strengthening exercises.  This 
observation was surprising as vertical lingual compression strength is a major contributor to both 
pressure generation and maintenance (Lazarus et al., 2003).  As patients with radiation/ 
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chemoradiation-induced dysphagia typically present with decreases in airway protection and 
increases in pharyngeal retention, it is logical to conclude that patients with radiation/ 
chemoradiation-induced dysphagia could potentially benefit from lingual exercise, as both of these 
patterns have been shown to be remediated by vertical lingual compression strength in other patient 
populations (Robbins et al., 2005; Robbins et al., 2007).  Therefore, the absence of lingual 
strengthening exercises should be noted. 
Additionally, it should be noted that while Carnaby-Mann et al. (2012) did include lingual 
strengthen exercise, the authors did not describe specific details regarding the protocols used, e.g. 
whether administered via IOPI or a tongue depressor.  Also, the effectiveness of the exercise 
program was tested as a single unit. Therefore the individual contributions of exercises could not 
be isolated.  This lack of isolation is problematic, due to the variability of patient needs present in 
this patient population.  Therefore, while the inclusion of this target was warranted, the specific 
contribution of lingual strengthening exercise still needs to be explored.   
Notably, a study by Lazarus (2014) examined the specific contributions of lingual 
strengthening exercise in patients with radiation/ chemoradiation-induced dysphagia, by 
comparing the performance of patients treated with lingual strengthening exercise via tongue 
depressor to a control group which did not receive lingual strengthening exercises.  At the end of 
the six-week treatment period, no differences were observed between groups in tongue strength, 
measured via an Iowa Oral Performance Instrument (IOPI) device, oropharyngeal swallow 
efficiency (Rademaker, Pauloski, Logemann, & Shanahan, 1994), or patient-reported quality of 
life (Funk, Karnell, Christensen, Moran, & Ricks, 2003).  The authors attributed these results to 
poor patient adherence levels and a short therapy period (Lazarus et al., 2014).    
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Another possible contribution to the null results could be related to the exercise protocol 
used in the study.  This protocol consisted of ten repetitions per practice session, five practice 
sessions per day, five days a week for six weeks.  While the researchers stated that this protocol 
was based on guidelines provided by the American College of Sports Medicine, no citation was 
provided.  This oversight is troubling as their protocol varied considerably from other researched 
protocols and conflicts with other recommendations for strength training given by the American 
College of Sports Medicine (American College of Sports Medicine, 1998).  This organization 
recommends that strength training exercises use high intensity/training resistance levels (defined 
as 75% - 90% maximal resistance), eight to 12 repetitions per set, with workouts occurring two to 
three days per week (American College of Sports Medicine, 1998).  Given the disparities between 
implemented and recommended protocols, it is possible that the paucity of evidence regarding 
lingual strength training after radiation therapy could be attributable to methodological flaws in 
the implementation of the exercise intervention.    
The successful application of the American College of Sports Medicine recommended 
strengthening protocols for other dysphagia patient populations lends support to this claim. For 
example, Robbins (2005), used Iowa Oral Performance Instrument (IOPI) devices with all 
participants.  In this way, accurate readings of lingual strength could be obtained for each 
participant throughout the study.  Also, the Iowa Oral Performance Instrument (IOPI) device 
allowed for the establishment of high intensity/ training resistance levels, as researchers could 
target specific exercise goals during each session.  The researchers took advantage of measurement 
precision enabled by device-mediation and based goals on recommendations from the ACSM and 
measurements of participants’ baseline maximal lingual strength (60% or 80%).  Maximal lingual 
strength was then recalculated at the end of the second, fourth, and sixth weeks of exercise 
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(Robbins et al., 2005).  In this way, the researchers could ensure that the exercises were using the 
principles of progressive resistance.  This study also asked participants to complete three sets of 
10 repetitions, three times per day, three days per week, by the recommendations for strength 
training provided by the American College of Sports Medicine (American College of Sports 
Medicine, 1998).  Also, Robbins (2005) also used a longer treatment period of eight weeks, vs. the 
six-week period of Lazarus (2014).  Interestingly, the authors of Lazarus (2014) did not provide a 
reason for this shortened therapy time frame.  As significant improvement for strength training 
was seen at four weeks, and even greater improvement was seen in eight weeks, this longer 
treatment period may have positively influenced outcome measures (Kays & Robbins, 2006).   
These methodological modifications in the deployment of the exercise protocol seem to have 
significance as seen by strong positive outcomes.  Especially since all subjects showed an increase 
in lingual strength, swallowing pressures, and in a subset of their participants, increases in overall 
lingual volume as measured via MRI  (Robbins et al., 2005).  Given these results, the application 
of a strength based isometric lingual exercise protocol warrants further investigation in patients 
following radiation/ chemoradiation treatments, as strength based lingual exercise protocols have 
not yet been demonstrated to be beneficial for patients with head and neck cancer.   
1.5 RESEARCH QUESTIONS 
To date, treatment information for patients with radiation/ chemoradiation-induced dysphagia is 
limited.  Specifically, the contributions of individual exercises to dysphagia rehabilitation remain 
unknown, particularly the contributions of device-mediated lingual strengthening exercises.  
Also, links between participant characteristics and treatment success are also unknown.  This 
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study aims to address these deficit areas by describing the experiences of six individual 
participants with radiation/ chemoradiation-induced dysphagia.   The aims of this study are listed 
below: 
AIM 1: to explore the effectiveness of the addition of a device-mediate lingual strengthening 
exercise protocol to “standard dysphagia therapy” by describing participant improvements in 
swallowing function through measures of airway protection and pharyngeal retention.   
Research Question 1: Do participants who complete a device-mediated lingual strengthening 
exercise protocol in addition to “standard dysphagia therapy” demonstrate more improvement in 
swallowing function (measured by airway protection and pharyngeal retention) than participants 
who only complete the “standard dysphagia therapy” treatment protocol? 
AIM 2: to explore whether patients with specific characteristics benefit most from this type of 
treatment. 
Research Question 2: What patient characteristics are shared by participants who show 
improvement (benefits) from dysphagia treatment (both “standard dysphagia therapy” and 
“standard dysphagia therapy” plus device-mediated lingual strengthening exercise)? 
It should be noted that these aims are a departure from the original aims of this study.  
Initially, this study aimed to investigate the effects of a device-mediated lingual strengthening 
exercise protocol on overall swallowing function as measured by seven kinematic durational 
measures in addition to measures of airway protection and pharyngeal retention.  However, 
following the completion of data collection and primary analysis, the researchers chose to 
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remove the seven kinematic durational measures from this thesis study.  Instead, these measures 
would be examined in more detail in the larger study.  This decision was made for study 
feasibility, due to the limited timeline available for masters thesis research.   
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2.0 METHODS 
For this study, a single-subject descriptive approach was used to analyze measures of airway 
protection and pharyngeal retention through a secondary examination of videofluoroscopic data.  
Descriptive data was also obtained regarding participant characteristics.  All data was collected 
from the initial six participants of a larger ongoing prospective experimental study.  This larger 
study examined treatment outcomes associated with the addition of device-mediated (IOPI) 
isometric lingual exercise therapy protocol to “standard dysphagia therapy” (clinician-directed) 
treatment in patients with radiation/ chemoradiation-induced dysphagia.  Appendix A details the 
methods used in the larger ongoing study.   
2.1 ETHICS 
The University of Pittsburgh Institutional Review Board approved the larger ongoing study, and 
all of the analyses performed in this study, on October 21, 2015 (PRO15080566).  The principal 
investigator of this thesis study was added as a member of the larger IRB approved study team, 
with the role of analyzing videofluoroscopic data, on July 8, 2016.   
2.2 STUDY DESIGN AND DESCRIPTION 
A pre-post single-subject design was used for this study; wherein each participant was examined 
individually.  Measures of airway protection and pharyngeal retention were obtained for each 
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participant via videofluoroscopic data.  Videofluoroscopic data was collected at the pre-dysphagia 
treatment stage, after which participants were assigned to groups (control or experimental).  
Participants assigned to the control group completed a “standard dysphagia therapy” protocol and 
participants assigned to the experimental group completed a “standard dysphagia therapy” protocol 
and a device-mediated lingual strengthening exercise protocol.  Videofluoroscopic data collection 
was then repeated at the post-dysphagia treatment stage.  Following completion of the study, the 
principal investigator (NB) was given information regarding participant characteristics.   
It is important to note that participant group assignments, videofluoroscopic data 
collection, and dysphagia treatment protocols were designed and completed by researchers in the 
larger ongoing study.  Brief descriptions of their methodology are included below; detailed 
information is listed in Appendix A. 
2.3 PARTICIPANTS, GROUP ASSIGNMENTS 
This study was comprised of the first six participants who completed the larger ongoing study (See 
Appendix A for details regarding participant recruitment and group assignment).  Three 
participants were assigned to the control group (by the larger ongoing study) and completed the 
“standard dysphagia therapy” protocol.  The remaining three participants were assigned to the 
experimental group (by the larger ongoing study) and completed the “standard dysphagia therapy” 
protocol in addition to a device-mediated lingual strengthening exercise protocol.    
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2.4 TREATMENT PROTOCOLS 
2.4.1  “Standard dysphagia therapy” treatment protocol 
The “standard dysphagia therapy” treatment protocol consisted of individual intervention plans 
and were not standardized across subjects.  Specifically, each participant was prescribed an 
individually tailored intervention plan by clinicians working at a tertiary teaching hospital.  All 
intervention strategies other than isometric lingual exercise were considered for inclusion into each 
participant’s “standard dysphagia therapy” intervention, including compensatory postures, texture 
modifications, and strengthening exercises targeting other dysphagia related muscle groups.  All 
participants, regardless of group assignment, completed the “standard dysphagia therapy” 
protocol.  For participants assigned to the control group, “standard dysphagia therapy” was the 
only treatment protocol completed.  Contrastingly, participants assigned to the experimental group 
completed “standard dysphagia therapy” in addition to a device-mediated lingual strengthening 
exercise protocol. 
It should be noted that the principal investigator of this thesis study (NB) did not have 
access to information regarding prescribed intervention plans until the study was completed.  At 
this time, it was discovered that not all of the clinicians followed the guidelines for the “standard 
dysphagia therapy” protocol.  Specifically, three participants received lingual strengthening 
exercises (administered via tongue depressor) as part of their “standard dysphagia therapy” 
intervention plans.   The exercises included each participant’s “standard dysphagia therapy” 
protocols are listed below in Table 2.   
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Table 2: Exercises prescribed in “Standard dysphagia therapy” 
Participant (Group) Exercises Prescribed in “Standard Dysphagia Therapy.” 
A (Experimental) None prescribed 
B (Control) Lingual strength via tongue depressor x15 
Lingual strength via finger to cheek x15 
Masako x10-15 
Effortful swallow 
Mendelsohn maneuver x10 
C (Experimental) Mandibular range of motion 
Masako x10 
Effortful swallow 
D (Control) Mandibular range of motion x10-15 
Lingual range of motion x10-15 
Masako x10-15 
Effortful swallow x10-15 
Base of tongue retraction x15 
E (Experimental) Effortful swallow x10-15 
Mandibular depression x10-15 
Lingual strength via tongue depressor (added week 3) 
F (Control) Lingual strength via tongue depressor (unknown repetitions) 
Masako x15 
Mandibular depression x15 
Mandibular range of motion x15 
Effortful swallow 
2.4.2 Device-mediated lingual strengthening exercise protocol 
In addition to “standard dysphagia therapy” interventions, those in the experimental group 
completed a device-mediated lingual strengthening exercise protocol.  Using the Iowa Oral 
Performance Instrument (IOPI), participants performed three sets of ten “press” repetitions daily, 
on three nonconsecutive days each week, over an eight-week period.  Unique exercise targets were 
set for each participant, based on assessment strength measures completed by the clinicians 
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according to the protocols of the larger ongoing study (See Appendix A for assessment methods), 
following the methods of Robbins et al. (2005).  Based on these methods, 60% of maximal 
isometric strength was the exercise target for the first week of treatment, which increased to 80% 
for weeks two through eight.  At the beginning of weeks three, five, and seven, maximum pressures 
were re-measured, and each participant’s 80% target was recalculated based on their new 
maximum pressure generation.  Table 3 below displays the exercise target valuation schedule.   
Table 3: Exercise treatment timeline 
Exercise Treatment Timeline Target Goal 
(% of baseline isometric maximal strength) 
Week 1 60% 
Week 2 80% 
Week 3 Recalculate max; 80% of new max 
Week 5 Recalculate max; 80% of new max 
Week 7 Recalculate max; 80% of new max 
(Robbins et al., 2005) 
2.5 VIDEOFLUOROSCOPIC DATA COLLECTION 
Videofluoroscopic data collection was performed by clinicians employed at a tertiary teaching 
hospital, including the principal investigators of the larger ongoing study.  Data collection was 
conducted according to the experimental protocols used in the larger ongoing study detailed in 
Appendix A.  During videofluoroscopy, clinicians had participants swallow an assortment of 
textures and volumes of contrast using a variety of patient postures.   However, not all texture-
volume-posture combinations were analyzed in this study.  Only descriptions of the swallow 
conditions analyses used in this study are listed below.  
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As the aim of this study was to examine the effects of lingual strengthening exercise and 
not swallow conditions, only two consistency/texture conditions, two delivery devices, and one 
patient posture condition were included for analysis. The two consistency/texture conditions 
included were Varibar Thin Liquid at less than five centipoise viscosity and Varibar Pudding-thick 
at 5000 centipoise viscosity.  The two delivery devices referred to the method of bolus delivery to 
the participant and included spoon or cup.   Spoon-administered thin liquid boluses were 
approximately three mL volume, and the volume of cup-administered thin liquid boluses was self-
selected by each participant and ranged from approximately five milliliters to 20 milliliters.  Spoon 
administered pudding boluses were approximately 15 milliliters.  In regards to patient posture, all 
swallows analyzed within this study featured neutral patient posture, meaning that no swallows 
featuring compensatory postures (such as a chin tuck or head turn) were included.   
For this study, all swallow conditions were represented in three texture- volume – posture 
combinations, which are listed below in Table 4.  Numerical category codes were created for 
swallow condition combinations before data measurement and analysis.  Each swallow condition 
featured three numbers which related to specific features.  For example, the first digit related to 
the delivery device, the second to consistency/ texture, and the third to posture.  Table 4, listed 
below, decodes the numerical swallow condition codes used in this study.   
Table 4: Description of swallow conditions 
Swallow Condition # Device Consistency/ texture Posture 
111 Spoon Varibar Thin Liquid Neutral 
211 Cup Varibar Thin Liquid Neutral 
4141 Spoon Pudding-thick Neutral 
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2.6 VIDEOFLUOROSCOPIC DATA MANAGEMENT 
All videofluoroscopic videos were de-identified (all participant identifying information was 
removed) at the time of recording using a bypass function within the Foresight Imaging TIMS 
Medical DICOM system (Foresight Imaging, 2016).  Videofluoroscopic digital videos were then 
converted into PicVideo MJPEG Codec files by the principal investigator (NB) using the Foresight 
Imaging TIMS Medical DICOM system (Foresight Imaging, 2016) in the Radiology department 
at UPMC Presbyterian Hospital.   The PicVideo MJEPG Codec files were then duplicated to 
portable media. Videofluoroscopic data were then stored in digital format in the swallowing 
research lab in the Department of Communication Science and Disorders at the University of 
Pittsburgh. 
2.7 MEASUREMENT 
For this study, measurements of airway protection and pharyngeal retention were conducted on 
videofluoroscopic data.  Measurements of airway protection were conducted after each swallow 
using the penetration-aspiration scale.  Penetration aspiration scale scores were completed by the 
principal investigator (NB), using Image J software (Rashband & Ferreria, 2016), for all swallows 
according to the descriptions listed below in Table 5.  
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Table 5: Penetration-aspiration scores 
Penetration-Aspiration Scale 
1 Material does not penetrate the larynx or enter the airway 
2 Material penetrates the larynx, but remains above the level of the vocal 
folds, and is ejected 
3 Material penetrates the larynx, remains above the level of the vocal folds, 
and is not ejected 
4 Material penetrates the larynx, contacts the vocal folds, and is ejected 
5 Material penetrates the larynx, contacts the vocal folds, and is not ejected 
6 Material penetrates the larynx, passes below the level of the vocal folds, 
and is ejected 
7 Material penetrates the larynx, passes below the level of the vocal folds, 
effort is made to eject material. However, the material is not ejected 
8 Material penetrates the larynx, passes below the level of the vocal folds, 
and no effort is made to eject material 
(Rosenbek et al., 1996) 
Measurements of pharyngeal retention were conducted by the principal investigator (NB), 
using an adapted pharyngeal retention scale.  This modified scale was created by Dr. James L 
Coyle, a dysphagia specialist, and Atsuko Kurosu, a Ph.D. candidate specializing in dysphagia, 
based on methodology published by Eisenhuber et al. (2002) and Lof & Robbins (1990).  The scale 
consists of five values.  Each scale value describes the height of the two-dimensional column of 
residue present in each cavity (valleculae and pyriform sinuses) which was measured using the 
line tool in the image processing software program (Rashband & Ferreria, 2016).  Line segments 
were digitally drawn in the vertical axis at the longest point of each residue column, and the 
midpoint marker of the segment was used to identify the point at which the residue column 
exceeded 50% of cavity height.   Visual inspection was used to determine whether residue 
exceeded 50% or 25% of cavity height.  Coating was defined as a one-dimensional line of contrast 
on the surface of the cavity after the swallow, and “no residue” was defined as no visible contrast.  
These scoring criteria are pictured below in Figure 3, and detailed descriptions of the scale values 
are listed below in Table 6.     
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Figure 3: Visual explanation of pharyngeal retention scale alterations 
Table 6: Pharyngeal retention scores 
Pharyngeal Retention Scale 
0 There is no visible residue 
1 The cavity is coated with a one-dimensional line of residue 
2 The cavity contains an area (with height and width) of residue that occupies less than 
25% of the height of the cavity. 
3 The cavity contains an area (with height and width) of residue that occupies between 
25% and 50% of the height of the cavity 
4 The cavity contains an area (with height and width) of residue that occupies greater 
than 50% of the height of the cavity. 
2.8 MEASUREMENT FIDELITY 
Observational measures are inherently subjective and open to personal interpretation (Cicchetti, 
1994).  As measurements taken on videofluoroscopic data are fundamentally observational in 
nature, researchers must take precautionary actions to ensure measurement fidelity.  For this study, 
concrete steps were taken to ensure measurement accuracy.  These measures included researcher 
blinding, researcher training, and reliability testing.  
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2.8.1 Blinding 
Before commencing measurement, the principal investigator (NB) was blinded to all identifying 
information regarding participants.  Specifically, participant numbers, study numbers, and 
videofluoroscopic swallow examination dates were removed from all files by the research mentor 
(JLC) and files were renamed numerically using computerized random number generation before 
measurement.  These steps were taken to blind the principal investigator (NB) from participant 
age, gender, tumor site, group assignment, and experimental phase (“pre” or “post” treatment).   
2.8.2 Training 
Before conducting measurements on the experimental data set, the principal investigator (NB) 
underwent measurement training at the University of Pittsburgh Swallowing Lab.  Her training 
was conducted with her research mentor (JLC), an expert in the kinematic analysis of 
videofluoroscopic data (including penetration-aspiration scale scores, and pharyngeal retention 
scores) and a co-principal investigator on the ongoing larger experimental study.  Training used 
de-identified videofluoroscopic images from participants in previously IRB approved studies, and 
consisted of demonstrations, guided instruction, performance feedback, and discussion.   In total, 
110 hours of training were completed including 25 hours of supervised instruction and 85 hours 
of individual practice.  Following training, the principal investigator (NB), who performed all data 
analysis for this thesis, underwent testing or both intra-rater and inter-rater reliability of all 
measures.  
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Reliability testing on training data included the initial analysis of 40 swallows from non-
study data on eleven kinematic events, penetration-aspiration scale scores, and pharyngeal 
retention scores.  Computerized random number generation was then used to selected 50% of the 
40 swallows, which were then re-scored by an expert judge (JLC).  These results are listed below 
in Table 7. 
Table 7: Initial inter-rater reliability results (training data) 
Measures ICC Result Description 
Kinematic Events .99-.98 Excellent 
PAS .918 Excellent 
PRS (pyriforms) .684 Poor 
PRS (valleculae) .85 Good 
Some inconsistencies were found.  These were then resolved through consensus between the 
principal investigator (NB) and the expert judge (JLC).  After reaching agreement, training data 
swallows were then re-scored by the principal investigator, and inter-rater reliability was then re-
calculated as described above.  These results are listed below in Table 8.  
Table 8: Inter-rater reliability results following consensus (training data) 
Measures ICC Result Description 
Kinematic Events .99-.98 Excellent 
PAS .994 Excellent 
PRS (pyriforms) .943 Excellent 
PRS (valleculae) .948 Excellent 
The principal investigator (NB) then used computerized random number generation again 
to select a different 50% of the 40 swallows to establish intra-rater reliability.  Statistical analysis 
for reliability consisted of Intra class correlation coefficient (ICC) calculations, made using IBM 
SPSS Statistics 23.  Determinations of “excellent,” “good,” “fair,” and “poor” reliability were 
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made according to the guidelines established by Cicchetti (1994).    These results are listed below 
in Table 9. 
Table 9: Intra-rater reliability testing results (training) 
Measures ICC Result Description 
Kinematic Events .99-.98 Excellent 
PAS .994 Excellent 
PRS (pyriforms) .943 Excellent 
PRS (valleculae) .948 Excellent 
2.8.3 Reliability testing (experimental data set) 
Both inter-rater reliability and intra-rater reliability were also established on the experimental data 
set.  Reliability was accomplished by randomly selecting ten percent of the data (ten swallows) to 
re-score all measures.  Randomization was accomplished via computerized random number 
generation. Ten swallows were then rescored by the research mentor (JLC), to establish inter-rater 
reliability. A different randomly selected ten swallows were then rescored by the principal 
investigator (NB), to establish intra-rater reliability.  Statistical analysis for reliability testing on 
the experimental data set used the same protocol as establishing reliability on training data, 
specifically ICC calculations and descriptive determinations according to values published by 
Cicchetti (1994).    Reliability testing results from the experimental data set are listed below in 
Table 10 (inter-rater reliability) and Table 11 (Intra-rater reliability). 
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Table 10: Inter-rater reliability testing results (experimental data set) 
Measures ICC Result Description 
Kinematic Events .94-1 Excellent 
PAS .970 Excellent 
PRS (pyriforms) .836 Good 
PRS (valleculae) .913 Excellent 
Table 11: Intra-rater reliability testing results (experimental data set) 
Measures ICC Result Description 
Kinematic Events .98-1 Excellent 
PAS .970 Excellent 
PRS (pyriforms) .981 Excellent 
PRS (valleculae) .966 Excellent 
2.9 ANALYSIS 
Following measurement completion, the analysis was conducted by the principal investigator 
(NB).  Quantitative data for airway protection and pharyngeal retention were also organized for 
each participant.  Measurement data were then averaged across trials within condition (i.e. all trails 
of 111 or thin liquid boluses via spoon).  Individual “pre-post” differences were found by 
subtracting the “post” mean value from the “pre” mean value.  Participant data were also 
normalized to the baseline to double check determinations of “improvement” and “no 
improvement.”  Normalization used the following transformation: "𝑃𝑜𝑠𝑡" 𝑚𝑒𝑎𝑛 𝑣𝑎𝑙𝑢𝑒 ÷
"Pre" 𝑚𝑒𝑎𝑛 𝑣𝑎𝑙𝑢𝑒 (𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒) = 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑣𝑎𝑙𝑢𝑒. Descriptive participant demographic data 
was also collected and arranged by age, gender, primary cancerous lesion location, tumor staging, 
and date participants completed radiation/ chemoradiation.   
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3.0 RESULTS 
Quantitative data, i.e. measures of patient airway protection and pharyngeal retention, were 
obtained from 12 videofluoroscopic swallow studies (93 swallows from six participants).  
Specifically, data were collected from all swallows assigned to the following conditions, 111 (thin 
liquid via spoon), 211 (thin liquid via cup) and 141 (pudding thick via spoon).   The number of 
swallows and measurements obtained varied by participant.   
Demographic data and medical history information were obtained from all six participants, 
regarding age, gender, and the date they completed radiation/ chemoradiation.  However, medical 
history information regarding primary cancerous lesion location and tumor staging could only be 
obtained for five of the six participants.  This information is displayed in Table 12 below.   
Table 12: Participant characteristics 
Participant Age Gender Lesion Location Staging Time Since CXRT 
Experimental Group 
A 67 F Not available Not available >1 year*
C 46 M L tonsil T2N2 2 months 
E 65 M Larynx T1N2 7.5 years 
Control Group 
B 62 M R tonsil T4N2 2 months 
D 56  M Base of Tongue T4N2 3 months 
F 52 M R tonsil T1N2 2 months 
*exact date was unspecified
Due to the single-subject nature of this study, all data was analyzed by individual 
participants.  Results will also be presented in this manner.  Specifically, listed below are individual 
sections for each participant wherein quantitative results are displayed, including airway protection 
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measures and pharyngeal retention, followed by descriptions of different participant 
characteristics. 
3.1.1 Participant A (experimental group) 
The data set for Participant A was complete, allowing airway protection measures (penetration-
aspiration scale scores) to made in all three swallow conditions, resulting in a total of eighteen 
average values.  Mean difference values, and normalized data both revealed that Participant A only 
showed improvement in airway protection in one swallow condition (211, thin liquid via cup).  No 
other improvements were noted across measures.  Average values, mean differences and 
normalized data are listed below in Table 13. 
Table 13: Penetration-aspiration scores, Participant A 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2.33 3 -.667 1.28 No 
211 3.75 3 .75 .8 Yes 
141 2 3 -1 1.5 No 
Pharyngeal residue measures were also made for Participant A in both the valleculae and 
pyriform sinuses, for all three swallow conditions.  Average values, mean differences and 
normalized data all demonstrate no improvement in pharyngeal retention between the “pre” and 
“post” treatment phases.  Table 14 below depicts pharyngeal retention data for Participant A in the 
valleculae.  Table 15 below illustrates pharyngeal retention data for Participant A in the pyriform 
sinuses.     
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Table 14: Pharyngeal retention scores (valleculae), Participant A 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 4 4 0 1 No 
211 4 4 0 1 No 
141 4 4 0 1 No 
Table 15: Pharyngeal retention scores (pyriform sinus), Participant A 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 3.667 4 -.33 1.01 No 
211 3.75 4 -.25 1.06 No 
141 1 2 -1 2 No 
In regards to participant characteristics, Participant A was a 67-year-old female. She 
completed radiation/ chemoradiation over one year before commencing dysphagia treatment, 
however the exact date she finished radiation/ chemoradiation was not provided to the principal 
investigator (NB). Further participant characteristic information, such as primary cancerous lesion 
location and tumor staging information could not be obtained for this participant.   
3.1.2 Participant C (experimental group) 
A complete data set was also available for Participant C. Therefore, measures of airway protection 
(penetration-aspiration scale scores) were completed in all swallow conditions, resulting in 18 
average values.  Both mean differences and normalized data revealed improved airway protection 
across all swallow conditions, for Participant C.  These values are displayed below in Table 16. 
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Table 16: Penetration-aspiration scores, Participant C  
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 4 1 3 .25 Yes 
211 1.4 1 .4 .71 Yes 
141 8 1 7 .125 Yes 
Pharyngeal retention measures were completed in all swallow conditions in both the 
valleculae and pyriform sinus, resulting in 36 average values.  Mean differences and normalized 
data both indicate that participant four demonstrated improvements in valleculae residue in 
swallow conditions 111 (thin liquids via spoon) and 211 (thin liquids via cup), but not 141 
(pudding via spoon).  In regards to pharyngeal retention in pyriform sinuses, Participant C 
improved in swallow condition 141 (pudding thick via spoon) but not in either of the thin liquid 
swallow conditions (111, thin liquid via spoon and 211, thin liquid via cup).  Average values, mean 
differences, and normalized data for pharyngeal retention scale scores in the valleculae are 
displayed below in Table 17.  Scores for the pyriform sinuses are presented below in Table 18.   
Table 17: Pharyngeal retention scores (valleculae), Participant C 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2.33 2 .33 .86 Yes 
211 4 3 .1 .75 Yes 
141 2 2 0 1 No 
Table 18: Pharyngeal retention scores (pyriform sinus), Participant C 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 1.667 2 -.33 1.19 No 
211 1.6 1.8 -.02 1.125 No 
141 2 .5 1.5 .25 Yes 
In regards to participant characteristics, Participant C was a 46-year-old male.  His primary 
lesion location was on the left tonsil.  This lesion was identified while still in early staging (T1N2).  
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Participant C also completed radiation/ chemoradiation approximately two months before 
commencing the experimental dysphagia treatment protocol and “standard dysphagia therapy” 
protocol.   
3.1.3 Participant E (experimental group) 
The data set for Participant E was incomplete. Specifically, a measurement of airway protection 
could not be obtained for pudding via spoon (141) during the “post” treatment phase. Therefore, 
mean differences and normalized data could not be obtained for airway protection for swallow 
condition 141 (pudding via spoon).  However, as the remaining two swallow conditions were 
complete, (111, thin liquid via spoon and 211, thin liquid via cup) these analyses were completed 
for the remaining two swallow conditions.  Results from these conditions show that Participant E 
made no improvements in airway protection during this study.  These results are listed below in 
Table 19. 
Table 19: Penetration-aspiration scores, Participant E 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 4 5 -1 1.25 No 
211 2 3.67 -1.67 1.84 No 
141 1 No data Unknown Unknown Unknown 
In regards to pharyngeal retention, average values were obtained for all swallow conditions 
in both the “pre” and “post” treatment phases, resulting in 36 average values.  Mean differences 
and data normalization revealed improvements in swallow condition 141 (pudding via spoon) in 
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both valleculae and pyriform sinus retention.  No other improvements were noted, as listed below 
in Table 20 and Table 21.   
Table 20: Pharyngeal retention scores (valleculae), Participant E 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2 2 0 1 No 
211 2.5 2.75 -.25 1.1 No 
141 4 3 1 .75 Yes 
Table 21: Pharyngeal retention scores (pyriform sinus), Participant E 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2 2 0 1 No 
211 2 2.25 -.25 1.13 No 
141 2 1.33 .67 .67 Yes 
Additionally, Participant E presented with the following characteristics.  His gender was 
male, and he was 65 at the time of treatment.  His primary cancerous lesion location was in the 
larynx, and he was diagnosed while in early staging, (T1N2).  Notably, over seven years had 
elapsed between finishing radiation/ chemoradiation and commencing the experimental dysphagia 
treatment protocol and “standard dysphagia therapy” protocol.   
3.1.4 Participant B (control group) 
In regards to airway protection, average values were obtained for swallow conditions 111 (thin 
liquid via spoon) and 211 (thin liquid via cup) in both the “pre” and “post” treatment phases.  
However, the data for airway protection in swallow condition 141 (pudding thick) was incomplete, 
therefore mean differences and data normalization could not be completed for this swallow 
condition.  The remaining two swallow conditions (111, thin liquid via spoon and 211, thin liquid 
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via cup) both indicated that improvements in airway protection were made by Participant B.  Table 
22, listed below, depicts airway protection results for Participant B. 
Table 22: Penetration-aspiration scores, Participant B  
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 5.5 5 .5 .91 Yes 
211 7 5.5 1.5 .79 Yes 
141 No data 7 Unknown Unknown Unknown 
Data for pharyngeal retention measures were also incomplete.  Specifically, no data was 
obtained in the “pre” phase for swallow condition 141 (pudding via spoon), meaning that average 
values and data normalization could not be conducted for this swallow condition. However, 
complete data was obtained for all other swallow conditions, resulting in eight average values.  
Mean differences and normalized data indicate that Participant B made no improvements 
in valleculae residue in any of the remaining swallow conditions.  In regards to the pyriform 
sinuses,  only one improvement was noted on swallow condition 111 (thin liquid via spoon).  No 
other improvements were found in pharyngeal retention.   Table 23 and Table 24 below depict 
pharyngeal retention results for Participant B.   
Table 23: Pharyngeal retention scores (valleculae), Participant B 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2.5 3.5 -1 1.4 No 
211 3 4 -1 1.33 No 
141 No data 4 Unknown Unknown Unknown 
Table 24: Pharyngeal retention scores (pyriform sinus), Participant B 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 4 3.67 .33 .92 Yes 
211 4 4 0 1 No 
141 No data 4 Unknown Unknown Unknown 
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Participant characteristics for Participant B were as follows.  He was a 62-year-old male, 
whose primary lesion location was in the right tonsil.  Participant B was diagnosed having 
advanced tumor staging, specifically T4N2.  Participant B commenced dysphagia treatment 
approximately two months after completing radiation/ chemoradiation.   
3.1.5 Participant D (control group) 
Participant D had a complete data set available for analysis.  In other words, average values were 
obtained for airway protection measures in both the “pre” and “post” phases for all three swallow 
conditions.  Mean differences and normalized data indicate that Participant D made improvements 
in airway protection on swallow condition 111 (thin liquid via spoon). However, no improvements 
were noted for swallow conditions 211 (thin liquid via cup) or 141 (pudding via spoon).  These 
results are listed below in Table 25.  
Table 25: Penetration-aspiration scores, Participant D 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2.5 2 .5 .8 Yes 
211 3 3 0 1 No 
141 1 2.33 -1.33 2.33 No 
Average values were also obtained for pharyngeal retention measures in both the “pre” and 
“post” phases for all three swallow conditions.  Mean differences and normalized data indicate 
that Participant D showed improvements in pharyngeal retention on swallow condition 111 (thin 
liquid via spoon) in both the valleculae and pyriform sinuses.  However, no other improvements 
were noted in pharyngeal retention.  Table 26 below depicts analyzed pharyngeal retention data 
(valleculae) for Participant D.  Table 27 below depicts analyzed pharyngeal retention data 
(pyriform sinuses) for Participant D.  
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Table 26: Pharyngeal retention scores (valleculae), Participant D 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 1.5 1 .5 .67 Yes 
211 1.67 2.25 -.58 1.35 No 
141 2.33 1 1.33 .43 Yes 
Table 27: Pharyngeal retention scores (pyriform sinus), Participant D 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 1 .5 .5 .5 Yes 
211 1.33 2.4 -1.07 1.8 No 
141 1.33 2 -1.67 1.5 No 
In regards to participant characteristics, Participant D was a 56-year-old male.  His primary 
cancerous lesion location was the base of tongue, and the tumor had advanced staging (T4N2).  
Approximately three months had elapsed between finishing radiation/ chemoradiation and 
commencing the “standard dysphagia therapy” treatment protocol.   
3.1.6 Participant F (control group) 
Participant F had an incomplete data set.  Therefore, average values were obtained for airway 
protection measures in both the “pre” and “post” phases for two of three swallow conditions (211, 
thin liquid via cup and 141, pudding via spoon).  However, an average value could only be obtained 
for the “pre” phase for the remaining swallow condition (111, thin liquid via spoon).  As a result, 
mean differences and data normalization could only be completed for the two complete swallow 
condition sets (211, thin liquid via cup and 141, pudding via spoon).     
56 
Mean differences and normalized data indicate that Participant F made improvements in 
airway protection in swallow condition 211 (thin liquid via cup), but not swallow condition 141 
(pudding via spoon).  These data are listed below in Table 28. 
Table 28: Penetration-aspiration scores, Participant F 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 1 No data Unknown Unknown Unknown 
211 3.8 1.4 2.4 .37 Yes 
141 1 1 0 1 No 
In regards to pharyngeal retention, data were also incomplete. Specifically, an average 
value could not be obtained for pharyngeal retention in the pyriform sinus in the “post” phase of 
swallow condition 111 (thin liquid via spoon).  Therefore, calculations could not be conducted for 
this measure.  However, all other data was complete.   
Mean differences and normalized data indicated no improvements in pharyngeal retention 
in the valleculae across all three swallow conditions.  Contrastingly, results also showed that 
Participant F made improvements in pharyngeal retention in the pyriform sinuses in the two 
swallow conditions assessed, specifically 211 (thin liquid via cup) and 141 (pudding via spoon).  
These results are displayed below in Table 29 and Table 30. 
Table 29: Pharyngeal retention scores (valleculae), Participant F 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2 2 0 1 No 
211 2.17 2.6 -.43 1.2 No 
141 2.5 2.67 -.17 1.07 No 
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Table 30: Pharyngeal retention scores (pyriform sinus), Participant F 
Condition “Pre” Average Value “Post” Average Value Difference Normalized Improvement? 
111 2 No data Unknown Unknown Unknown 
211 1.83 1.6 .23 .87 Yes 
141 2 1.67 .33 .84 Yes 
In regards to participant characteristics, Participant F was a 52-year-old male, diagnosed 
with a primary lesion location of the right tonsil.  This participant was diagnosed while his tumor 
was still in early staging, specifically T1N2.  Approximately 2-months had elapsed between his 
finishing radiation/ chemoradiation and commencing “standard dysphagia therapy” treatment.   
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4.0 DISCUSSION 
This study is the first to describe the efficacy of a device-mediated lingual strengthening protocol 
in patients with radiation/ chemoradiation- induced dysphagia, as measured by airway protection 
and pharyngeal retention.  Additionally, it is also the first study to make observations regarding 
specific participant characteristics that coincide with greater improvement in this patient 
population.  While this study did not produce robust results, useful observations may still be made 
from the data.  
4.1 RESEARCH QUESTION 1 
Do participants who complete a device-mediated lingual strengthening exercise protocol in 
addition to “standard dysphagia therapy” demonstrate greater improvements in swallowing 
function (measured by airway protection and pharyngeal retention) than participants who only 
completed the “standard dysphagia therapy” treatment protocol? 
When examining participants by group assignment, no distinct patterns of improvement were 
noted.  More specifically, five of six participants appeared to have similar rates of improvements 
in airway protection regardless of group assignment.  For example, Participant C and Participant 
B were the only participants who demonstrated improvements in all of the observed swallow 
conditions (notably condition 141, pudding via spoon, could not be assessed for Participant B due 
to incomplete data), and these participants were assigned to different groups.  Specifically, 
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Participant C was assigned to the experimental group and received device-mediated lingual 
strengthening exercise in addition to “standard dysphagia therapy.”  Whereas, Participant B was 
assigned to the control group and received “standard dysphagia therapy” only.   These results 
indicate that participants assigned to both the experimental group and control group could 
experience similar levels of improvements in airway protection.   
This observation was further supported by the remaining participants’ performance.  
Specifically, the two remaining control group participants, Participant D, and Participant F, only 
demonstrated improvements in airway protection on one swallow condition.  Similarly, Participant 
E (experimental group) also only showed improvement in one swallow condition.  Once again, the 
grossly equivalent performance of participants in different groups indicated that both experienced 
similar rates of improvement.  
Analysis of pharyngeal retention measures demonstrated similar results in the same five 
participants.  Two members of the control group, Participant F and Participant D, presented with 
improvements in six of nine conditions.  One member of the experimental group, Participant C, 
did as well.  The last member of the control group, Participant B, presented with improvements in 
one of five observations, and Participant F of the experimental group presented with two of six, 
similar values.  
Given the relatively balanced nature of the improvements made by the previously 
mentioned five individuals, we cannot conclude that device-mediated lingual strengthening 
exercise confers greater benefits than “standard dysphagia therapy” alone.  However, other factors 
may have contributed to these results.  First, the principal investigator (NB) did not have access to 
any information regarding patient compliance.  Given that reduced treatment adherence has been 
demonstrated in this patient population (Lazarus et al., 2014; Logemann et al., 2008), this factor 
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is impossible to rule out.  Additionally, missing data limited analyses for four participants. 
Therefore readers should use caution when interpreting these results, as they might not be fully 
representational of actual participant performance.   Last, confounding may have played a role in 
creating these results as well, as most of the participants in the control group received lingual 
strengthening exercises comparable to those received by the experimental group.   
Interestingly, confounding, due to prescribed exercises, opened the doors for an exciting 
comparison.  Current literature demonstrates that lingual strengthening exercises administered via 
tongue depressors may achieve similar results to fancier device-mediated forms of the exercise (C. 
Lazarus, J. A. Logemann, C. F. Huang, & A. W. Rademaker, 2003).  Our findings reflect these 
previously published results, as no distinct differences were noted between participants who 
completed the device-mediated lingual strengthening protocol and those who completed lingual 
strengthening exercises administered via tongue depressor as a part of their “standard dysphagia 
therapy.”  In this way, this study inadvertently allowed for replication of this concept in patients 
with head and neck cancer, enabling findings to contribute to a lacking area of the research 
literature.  This contribution could also prove to be significant, given the current high costs of 
health care in this country.  However, since this study was limited and not an exact replication, 
and the sample was very small, further research needs to be done to confirm these findings.   
One important caveat needs to be mentioned regarding the equal performance levels 
achieved through different administrations of lingual exercise, and that is that the only 
participant who did not receive lingual strengthening exercises in his “standard dysphagia 
therapy” protocol (Participant D) made similar improvements in overall swallowing function as 
the participants that did.  Therefore, this study’s findings could also indicate that lingual 
strengthening exercise may not be beneficial in patients with radiation/ chemoradiation-induced 
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dysphagia.  Current dysphagia literature provides support for this interpretation as well.  
Specifically, Lazarus et al. (2014), found no benefit in groups in tongue strength, oropharyngeal 
swallow efficiency, or patient-reported quality of life for patients with radiation/ chemoradiation-
induced dysphagia from lingual strengthening exercises administered via tongue depressor.  As 
our findings could support this conclusion, more research needs to be done regarding the validity 
of using these exercises in patients with radiation/ chemoradiation-induced dysphagia.   
This need for more research is also reflected in our findings for Participant A.  This 
participant made no improvements in airway protection or pharyngeal retention over the course of 
this study, despite receiving both “standard dysphagia therapy” and a device-mediated lingual 
strengthening exercise protocol.  While these results may be attributed to many factors, such as 
compliance, pain, or even depression, her results add interesting information to the dysphagia 
literature.  Specifically, that treatment is not always effective for patients with radiation/ 
chemoradiation-induced dysphagia.   However, another way one could view these results would 
be through the lens of her medical history.  Specifically, over one year had elapsed between when 
she finished radiation/ chemoradiation, and when she began dysphagia treatment.  Given the 
progressive nature of radiation/ chemoradiation-induced dysphagia symptoms, one could argue 
that a finding showing no improvement, but little regression is actually a positive result.  Current 
research literature can neither support or refute this interpretation.  Therefore, more work must be 
done to identify what constitutes an improvement in this patient population.    
In summary, while our results did not provide robust evidence regarding the question we 
set out to answer, the data obtained opened doors to new questions and provided support to 
existing information in the research literature.  Specifically, our data showed that tongue 
depressors might be as effective as more expensive device-mediated lingual strengthening 
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exercises protocols.  We also demonstrated that there is a possibility that lingual strengthening 
exercise does not benefit this patient population, and that more research needs to be conducted to 
explore why.  Last, our results also highlighted a paucity in the research literature regarding the 
definition of patient “improvement” in this patient population.   Therefore, while our findings 
lend support, more research needs to be done.   
4.2 RESEARCH QUESTION 2 
What patient characteristics are shared by participants who showed improvement (benefits) from 
this form of dysphagia treatment? 
The patient characteristic data obtained by this study revealed both commonalities and wide 
variation within the participants.   Areas of commonality included gender and age.  However, 
tumor location, staging, and time since radiation/ chemoradiation varied widely between 
participants.  In regards to the participants who demonstrated improvements, observed common 
characteristics related to the timing of treatment, and primary lesion location.  Interestingly, other 
characteristics, including tumor staging, participant age, and participant gender were not observed 
to be closely associated with either improvement or no improvement.   These findings may 
contribute to a first-step towards guiding clinicians to create individualized dysphagia intervention 
plans.   
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4.2.1   Timing
Firstly, the data indicated that patients who had finished radiation/ chemoradiation over one-year 
before starting dysphagia treatment experienced less overall improvement than participants who 
began dysphagia treatment approximately two months after finishing radiation/ chemoradiation.   
Specifically, participants C, B, D, and F experienced higher levels of improvement, than 
participants A and E.  Interestingly, participants C, B, D, and F also pursued dysphagia treatment 
approximately two months after completing radiation/ chemoradiation.  In contrast, Participant A 
had over one year lapse between radiation/ chemoradiation and commencing dysphagia treatment, 
as did Participant E, who had more than seven years elapse.  This observation is further supported 
because it is consistent with established findings in the dysphagia research literature (Lazarus et 
al., 2000). Therefore, the findings from this study combined with previously established findings 
(Lazarus et al., 2000) indicate that patients who have recently completed radiation/ chemoradiation 
may be the most appropriate for this type of intervention.    
4.2.2   Location
Only three primary lesion locations were reported by participants in this study; the tonsils, the 
larynx, or the base of tongue.  Lesion location information could not be obtained for one participant 
(Participant A).  Participant E was the only participant who presented with a primary lesion in the 
larynx.  While this participant experienced some improvement, there were no other participants 
who matched this characteristic. Therefore results could not be replicated through the multiple 
baselines aspect of this study, and no real observations can be made regarding this lesion location.  
The same goes for lesions on the base of tongue as Participant D was the only participant who 
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reported presenting with a primary lesion in this area.  However, observations could be made 
regarding primary lesions in the tonsillar region as three participants reported primary lesions in 
this area.    
Interestingly, the participant who demonstrated the greatest amount of swallowing 
improvement, and the participant that showed the second highest amount of swallowing 
improvement, both reported having had primary lesions in the tonsillar area.  Specifically, 
Participant C showed the most considerable improvements in overall swallowing function as 
measured by airway protection and pharyngeal retention, in six of nine total opportunities (i.e. 
either airway protection and pharyngeal retention in all three swallow conditions).  Participant B 
demonstrated the second greatest level of overall improvements, by improving in four of six total 
observations.  These results indicate that exercise therapy may be beneficial for patients with 
lesions in the tonsillar region  
However, it should be noted that Participant F also had a primary lesion in the tonsillar 
region, but he experienced a smaller proportion of improvement than participants B and C.  More 
specifically, Participant F only showed improvements in airway protection and pharyngeal 
retention in three of the seven swallow conditions.  However, it should be noted that the data set 
for this participant was incomplete. Therefore these results might not be representational, as it 
cannot be determined if this participant would have shown a more similar response to treatment 
overall if data could have been obtained for other observations.    
4.2.3   Staging
In contrast to lesion location, tumor staging was not observed to coincide with participant results.  
For example, as previously discussed, Participant C and Participant B both had tonsillar cancers 
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and experienced similar rates of improvements.  However, these two participants had remarkably 
different tumor staging.  Specifically, Participant C was in the early stages (T2N2) while Participant 
B had more advanced staging (T4N2).  This result indicates that this form of treatment may be 
appropriate for multiple stages of cancer.  Interestingly, this result was further supported by the 
fact that tumor staging did not appear to influence results in the remainder of participants as no 
pattern could be detected.  While the findings from this study were hardly conclusive, they may 
indicate that patients with a variety of tumor staging may benefit from this form of treatment.      
4.2.4   Age and gender
Participant age ranges spanned approximately 21 years, as the youngest participant was 46 
(Participant C), and the oldest was 67 (Participant A). Of note, the oldest participant showed the 
least amount of improvement, and the youngest participant showed the greatest.  Therefore, age 
may be a very important factor in participant performance that needs to be tested with a larger 
sample under more controlled experimental conditions.  Current research literature also supports 
this observation and the need for more research.  Specifically, healthy people with advanced age 
present with differences in oropharyngeal movement patterns and temporospatial swallowing 
durations which may lead to the development of dysphagia (Gleeson, 1999; Logemann, 1990; 
Robbins, Levine, Wood, Roecker, & Luschei, 1995).   While elderly patients with head and neck 
cancer may also present with these patterns, they are also at higher risk for associated 
complications due to primary cancer treatments such as polypharmacy and tissue toxicity 
(Maggiore et al., 2013; Maggiore et al., 2014).  To date, it is unclear how much these co-occurring 
conditions contribute to patient outcomes as opposed to changes in swallowing associated with 
age, particularly since research has also demonstrated that some elderly patients with head and 
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neck cancer benefit from aggressive treatments (Maggiore et al., 2013).  Therefore, while our 
results suggest that aging may adversely impact treatment outcomes, this is far from conclusive.  
More controlled research is needed to pinpoint whether aging is the causal factor, or whether these 
differences should be more accurately attributed to co-occurring conditions common in the aging 
population.   
In regards to gender, only one participant identified as female (Participant A), whereas all 
of the other participants identified as male (Participants B, C, D, E, and F).  As previously 
discussed, Participant A presented with the least amount of improvement in the study.  Once again, 
while it is interesting that the only female participant did not benefit from this form of treatment,  
one participant’s experience is hardly generalizable to females in general.  Therefore, more 
research needs to be done examining the effects of gender on treatment outcomes for patients with 
radiation/ chemoradiation-induced dysphagia.  
4.2.5   Summary
In summary, observations from this study data indicate that two patient characteristics may 
associate with greater improvements, specifically time since treatment and lesion location.  
Therefore, patients with these characteristics may be the most appropriate for this type of 
intervention. However, more research is needed to confirm this claim.  As for the other participant 
characteristics examined, no observations could be made which coincided with participant 
performance.  Therefore, more research is needed in this area to explore how different patients 
respond to dysphagia treatment.   
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4.3 STUDY STRENGTHS AND LIMITATIONS 
This study featured both strengths and limitations.  First, the major strength of this study was its 
high degree of external validity, by reflecting a “real-life” approach to standard dysphagia therapy.  
In clinical practice, clinician judgment forms the standard of care, and compensatory and 
rehabilitative techniques are prescribed for each patient based on their clinician’s best judgment.  
Unfortunately, there is a large amount of variation both within and between clinicians in “real 
world” clinical practice.  This variation was reflected in the uncontrolled nature of the standard 
dysphagia protocol used in this study. Therefore, the results obtained will be more reflective of 
what “real world” clinicians might expect, especially since the experimental protocol added to 
standard treatment within the study was very highly controlled.  Because of this, the effects 
measured in this study can be confidently attributed to the addition of device-mediated isometric 
lingual strengthening exercises.   
This study also featured major limitations.  First, this study featured limited internal 
validity, due to the pre-post design, as the limited observations made it difficult to guarantee that 
results were caused by the experimental treatment and nothing else.  While the multiple baselines 
across subjects feature of the design are supposed to guard against making this type of error, the 
heterogeneity of both participant and treatment-related factors limited effectiveness and prohibited 
accurate replication. 
Vagueness in the device-mediated lingual strengthening exercise protocol may have also 
impacted the validity of results of this study, as the experimental protocol did not outline where 
exactly the IOPI bulb should be placed against the hard palate while completing the experimental 
exercise protocol.  As different intrinsic muscles of the tongue account for various tongue 
movements, different bulb placements may target different intrinsic lingual muscles.  Additionally, 
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there was no protocol in place to account for any bulb slippage which could occur during the 
implementation of exercises tasks.  As slippage could also alter results, by creating deceptively 
small pressure measures, bulb slippage could also be a source of confounding.   
Inconsistent adherence to the experimental protocols during data collection was another 
limitation of this study.  Specifically, not all of the treating clinicians and radiologists followed the 
experimental protocols consistently while conducting the videofluoroscopic swallow study 
evaluations.  As a result, the final data set was incomplete and contained limited observations per 
person.  In fact, many participants had no observations in specific swallow conditions in either 
their “pre” or “post” studies, which severely limited the options for analysis.  However, it is 
important to note that some of these alterations in the protocol were driven by observations of 
patient swallow function and clinical intervention priorities.   
Clinicians also did not fully adhere to guidelines when prescribing exercises included in 
the “standard dysphagia therapy” protocol, for reasons unknown to the principal investigator (NB). 
Specifically, the original experimental protocol in the larger ongoing study defined “standard 
dysphagia therapy” as including any exercise other than those targeting lingual strength.  However, 
after completion of the study it was discovered that two participants in the control group 
(Participant B and Participant F) were prescribed lingual strengthening exercises via tongue 
depressor as a part of their “standard dysphagia therapy” protocols.  This inclusion of lingual 
strengthening exercise likely led to confounding, as the effects of lingual strengthening exercise 
can no longer be isolated since participants in both groups received some form of this type of 
exercise.  Additionally, one participant in the experimental group, Participant E, was prescribed 
lingual strengthening exercises via tongue depressor as part of his “standard dysphagia therapy” 
protocol in addition to completing the device-mediated lingual strengthening exercise protocol.  
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This addition was problematic as both device-mediated and exercise administered via tongue 
depressor target the same thing, lingual strength.  Therefore, as this participant completed more 
exercise than participants in the experimental group, it is impossible to attribute improvements he 
made in his swallowing to the device-mediated lingual strengthening protocol.  In this way, 
inconsistent adherence to the experimental protocols regarding the prescription of lingual 
strengthening exercises within the “standard dysphagia therapy” protocols could have confounded 
the results of this study.  Additionally, methodological considerations regarding clinician training 
in future studies should include the importance of adherence to scientific rigor by clinical staff 
during experimental research.   
Last, videofluoroscopic films were recorded at a slower frame rate than what was originally 
planned by the principal investigators of the larger ongoing study (15 frames per second vs. 30 
frames per second).  As slower frame rates have been linked to less accurate observational analysis 
(Bonilha et al., 2013), measurement errors made due to a slower frame rate cannot be ruled out of 
this study.  However, the magnitude of such errors would be no more than one-fifteenth of a second 
for any single durational measure and not likely to be systematic.  
For future research, greater internal validity could be achieved with a more robust single-
subject design such as alternating treatments or reversal/ withdrawal.  If feasibility inhibited these 
options, then matching participants on all participant and situation variables could also decrease 
variability and improve internal validity.  Additionally, future researchers could achieve more 
reliable results by using a faster frame rate and establishing formal documentation methods of 
medically necessary alterations of experimental protocol.   In this way, necessary departures could 
be factored into statistical analysis.  Last, future research could obtain more accurate results by 
establishing a formal training system to train prescribing clinicians in the exact nature of exercises 
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that should be included in the treatment protocols received by both the experimental and control 
groups.   
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5.0 CONCLUSION 
Eating and drinking are fundamental aspects of the human experience, due to survival needs, 
comfort practices, cultural practices, and spiritual beliefs.  A disruption in the ability to swallow 
therefore creates various adverse outcomes for patients, including negative personal health issues 
as well as psychosocial outcomes.   This potential for negative consequences applies in particular 
for patients with radiation/ chemoradiation-induced dysphagia, due to the complexity of their 
underlying illness and the severity of swallowing disorders.  Treating dysphagia in this patient 
population is one way that health care providers may work to improve patient outcomes in this 
particular patient population.   However, the current research literature is not substantiated enough 
to guide intervention practices entirely. 
5.1 SUMMARY 
This study examined whether participants with radiation/ chemoradiation-induced dysphagia who 
completed device-mediated lingual strengthening exercises in addition to “standard dysphagia 
therapy” demonstrated greater improvements in airway protection and pharyngeal retention than 
those treated with “standard dysphagia therapy” alone.  No consistent improvements were found 
to support the addition of device-mediated lingual strengthening exercise to “standard dysphagia 
therapy,” possibly due to variations in the small sample size and flaws in methodology.   
This study also examined some participant characteristics, in the hopes to inform future 
researchers and clinicians about which patients may benefit the most from this type of intervention.  
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Two observations were made regarding these characteristics.  First, participants with the least 
amount of time-lapse between finishing radiation/ chemoradiation and commencing dysphagia 
treatment showed the greatest amount of overall improvement in both airway protection and 
pharyngeal retention.   Second, participants with lesions in the tonsillar region also demonstrated 
higher levels of improvement following both “standard dysphagia therapy” and device-mediated 
lingual strengthening exercise in addition to “standard dysphagia therapy.” These results indicate 
that patients with specific characteristics may stand to benefit from exercise treatment protocols. 
However, more research is needed to examine this claim.     
5.2 SIGNIFICANCE 
The dysphagia research literature does not currently have robust findings regarding how specific 
exercises impact swallowing function in patients with radiation/ chemoradiation-induced 
dysphagia. Nor does the research literature contain substantial information concerning participant 
characteristics and how they influence choosing one form of treatment over another.  As dysphagia 
intervention must be individualized to the patient to be effective, these specific areas need to be 
explored further for clinicians to provide treatment in an effective and responsible manner.  
Therefore, this study is significant because it contributes information to two sparse areas of the 
research literature.    
First, the findings are significant because they provide support to existing information in 
the research literature.  Specifically, that tongue depressors might be equally effective to device-
mediated lingual strengthening exercises protocols, and that lingual strengthening exercise may 
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not significantly benefit this patient population.  However, more controlled research on a larger 
scale needs to be conducted to ascertain why.  Additionally, our results highlighted a paucity in 
the research literature regarding the definition of patient “improvement” in this patient population.   
Therefore, out findings are significant because they lend support to these larger findings and 
highlight new questions for researchers to explore.   
Additionally, this study identified two specific characteristics which may help researchers 
and clinicians identify patients who may benefit from this form of intervention, specifically 
participants with primary lesions in the tonsillar regions and who recently completed radiation/ 
chemoradiation treatments may be the most appropriate for this kind of intervention.  Therefore, 
while this study does not lend robust evidence to the hypothesized research questions, our findings 
are still significant because they contribute information to lacking areas of the research literature.  
74 
APPENDIX A 
METHODS OF THE LARGER ONGOING STUDY 
Specific Aims 
 To determine the effects of an eight-week device-mediated (IOPI) progressive lingual
strengthening exercise program on lingual strength in patients with head and neck cancer.
 To determine the effects of an eight-week device-mediated (IOPI) progressive lingual
strengthening exercise therapy program on:
o Oral intake
o Patient perception of impairment
o Patient quality of life
Hypothesis When added to standard dysphagia therapy, device-mediated progressive resistive 
isometric lingual exercise will produce greater gains in lingual strength, oral intake, pharyngeal 
retention, and psychometric measures than standard therapy alone.   
Dependent Variables The dependent variables included within this larger study are lingual 
strength, oral intake, Eat-10 questionnaire scores, and patient-reported severity of the disorder.     
Design and Ethics The larger ongoing study is a prospective, experimental cohort study with a 
cross-over phase for patients in the control group, with the alternating assignment of participants 
to experimental and control groups.  This study was approved by the Institutional Review Board 
of the University of Pittsburgh in November 2015 (PRO15080566). Written informed consent was 
obtained from all participants upon enrollment in the study. 
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Participants Participant recruitment occurs during evaluation in the Swallowing Disorders Center 
by the team physician and Speech Language Pathologist.   
There are two inclusionary criteria.  First, having been non-surgically treated with radiation 
or chemoradiation therapy for oral, oropharyngeal, hypopharyngeal, or laryngeal cancer and 
developed treatment associated dysphagia.  Second, a minimum of one month was required to have 
transpired between the final radiation treatment and the initial study procedures, to ensure that 
acute effects of radiation/chemoradiation had subsided. There was no maximum post-treatment 
interval required for inclusion. 
There are four exclusionary criteria.  First, includes any cognitive deficits interfering with 
the participant’s ability to adhere to assigned therapy program or ability to give informed consent.  
Second, a history of surgical treatment for head and neck cancer. Third, having a past or current 
history of temporomandibular joint dysfunction.  Fourth, having a past or current history of 
myofascial pain disorders.   
Consenting participants are alternately assigned to the two groups (experimental, control) 
based on the date of informed consent.  The alternating assignment is used to avoid chronological 
bias and to maintain equal participant numbers within each group.  Participants are assigned to 
either the control group (standard dysphagia treatment based on analysis of impairments) or 
experimental group (standard dysphagia treatment based on analysis of impairments plus device-
mediated progressive resistive isometric lingual exercise using the IOPI device).  Participants 
assigned to the control group are invited to cross over into the experimental protocol following 
completion of the eight-week dysphagia treatment phase.  This study will conclude after 34 
participants have completed protocols, 17 experimental and 17 control.   
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Dysphagia Assessment Phase Once eligibility was verified, and informed consent obtained, all 
participants underwent both instrumental and non-instrumental assessment measures. All 
assessments were completed by SLPs employed at UPMC including the primary researchers of 
the larger ongoing study.  Research protocols were followed during each of these assessments, 
unless clinical needs superseded in the interest of participant safety.   
Instrumental assessments consist of a Modified Barium Swallow Study (MBSS).  All 
MBSS studies were performed on a Toshiba’s Ultimax-i™ FPD system, set to 30 pulses per 
second.  Recording utilized a Foresight Imaging TIMS Medical DICOM system (Foresight 
Imaging, 2016) at 15 frames per second.   
Research protocol requires each participant to complete nine swallows, three in each of the 
three conditions.  The first condition consists of command swallows of three-milliliter spoon thin 
liquid boluses in a neutral posture. The second condition consists of command swallows of three-
milliliter spoon pudding thick boluses in a neutral posture.  The third condition consisted of 
voluntary swallows of thin liquid boluses consumed freely from a cup in a neutral posture.  All 
exams begin with the first condition.  Upon completion of these conditions, additional swallows 
may be recorded, about individual treatment needs.  However, these swallows are not standardized 
and not included in experimental data. 
Following the initial VFS study, patient isometric lingual strength is measured via the IOPI 
device.  The IOPI pressure sensor is placed against participants’ hard palate, and clinicians give 
instructions to, “Push as hard as you can,” for 30 seconds.  Measurement is repeated five times.  
The average of the values of the five trials is then used to compute baseline lingual strength.    
A Visual Analog Scale (VAS) is also administered to assess participants’ perception of 
their swallowing problems (Boonstra, Schiphorst Preuper, Reneman, Posthumus, & Stewart, 
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2008).   This scale consists of a 100 mm line numbered from 0-100.  Participants are instructed to 
mark an “X” that is representative of their perceived problems with “0” representing no problems 
and “100” extremely severe problems.   
The EAT-10 dietary questionnaire is also administered by clinicians as a standardized tool 
to describe both patient quality of life and feeding status (Cheney et al., 2015).  The Function Oral 
Intake Scale (FOIS) is completed by the treating clinician to rate the participants’ current levels of 
oral intake (Crary, Mann, & Groher, 2005).  Last, participants are weighed by their treating 
clinician to track adequacy of nutritional intake.   
Treating clinicians prescribe all participants “standard dysphagia therapy” interventions, 
consisting of interventions other than lingual strengthening exercises, and train participants in 
these interventions.  Decisions regarding the prescription of dysphagia interventions are made by 
the SLP based entirely on clinical factors including participant impairments and clinician 
judgment.  This training includes compensatory swallow maneuvers, range of motion exercises, 
as well as dietary and texture modifications.   
Experimental participants additionally receive 30-minutes of training in the operation of 
the IOPI device and performance of the experimental exercise protocol.  Daily exercise logs are 
dispensed for participants to record all therapy activities performed outside of the clinic. 
Dysphagia Treatment Phase Dysphagia treatment commences immediately following 
assessment procedures, consisting of an eight-week therapy regimen.   
Participants assigned to the control group complete their individually prescribed “standard 
dysphagia therapy” interventions throughout this eight-week period.  All dysphagia treatments 
other than isometric lingual exercises are considered for participants in this group, as isometric 
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exercise has not currently been proven beneficial.  After the eighth week of dysphagia treatment, 
participants in the control group are invited to cross over into the experimental protocol, continuing 
with standard intervention with the addition of IOPI mediated resistive isometric exercises.  
Participants assigned to the experimental group complete their individually prescribed 
“standard dysphagia therapy” interventions throughout this eight-week period.  In addition to the 
“standard dysphagia therapy,” participants within the experimental group also complete device-
mediated progressive resistive isometric exercises.  Participants perform three sets of ten 
repetitions of isometric lingual “presses” daily for three nonconsecutive days per week, 
compressing the IOPI sensor between the tongue and hard palate for three seconds per repetition.  
Exercise targets for this protocol are based on assessment strength measures, which are calculated 
based on the methods of Robbins et al. (2005).  Based on these methods, 60% of maximal isometric 
strength is the exercise target for the first week of treatment, increasing to 80% for weeks two 
through eight.  At the beginning of weeks three, five, and seven, strength was re-measured and the 
80% target recalculated.  Exercise logs are used to enhance compliance.  For all participants, 
UPMC clinicians re-administer all measures completed during the assessment phase at the end of 
the eighth week of the research procedures to determine outcomes measures.   
Cross-Over Phase Participants in the control group who choose to cross over into the 
experimental protocol continue with their prescribed “standard dysphagia therapy” interventions 
with the addition of IOPI mediated resistive isometric exercises.  These participants undergo all 
assessment measures again at the end of week 16. 
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